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Neural tube defects (NTDs) are among the most common serious birth 
defects, occurring in 0.5-10 per 1000 live births globally. Clinical studies have 
shown that periconceptional supplementation with folic acid (FA) can reduce 
NTD’s by up to 70%. The mechanism(s) by which FA prevents NTDs is an area 
of active research. 
Lrp6 provides two mice models of NTD that exhibit altered prevalence 
under FA supplementation. Crooked tail mice (Lrp6Cd/+) are rescued by FA 
supplementation, while Lrp6 deficient mice (Lrp6-/-) show increased rates of 
absorption and embryonic lethality under supplementation. We assayed the 
methylomes of heterozygous Cd and KO E9.5 mice. To analyze this data, we 
created the multiDiff package. It implements the novel maximum difference 
estimate for assigning biologically meaningful effects in complex designs. 
multiDiff displays consistently superior performance while varying simulation 
parameters as measured by AUC compared to DSS-general, a competing 
method (p<2.2-16, paired t-test). 
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Integrative analyses found that Rn45s showed FA-associated differential 
expression and differential promoter methylation on the KO background. The 
analysis suggests that FA primarily acts in an independent rather than additive or 
combinatorial manner on methylation and expression. Genes associated with an 
independent mechanism of action were enriched for transcriptional regulation. On 
the Cd background, we noted genes affected by FA that had known links to Lrp6 
biology, with the greatest number being associated with RhoA, suggesting 
involvement in the planar cell polarity Wnt signaling pathway.  
Methylation was also assayed in whole blood from P2 animals. We found 
43 persistently differentially methylated sites associated with the Cd mutation, 
and 25 with the KO mutation. Persistently differentially methylation loci 
associated with FA was identified at 86 sites in the Cd background, and 208 in 
the KO background.  
Before concluding, we discuss preliminary analyses of epigenetic and 
genetic data in human NTD patients, with a focus on ongoing challenges in the 
field. The continuing growth of public datasets, especially in other neurological 
disorders such as autism, combined with advances in sequencing technology, 
and improvements in analytical methods are giving modern NTD researchers the 
tools to overcome these challenges.
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CHAPTER 1 
 
Introduction: 
Neural Tube Defects and Folic Acid 
 
1.1 Background on Neural Tube Defects 
 
Neural tube defects (NTDs) affect an estimated 300,000 infants annually 
worldwide, making them second only to second only to congenital heart 
anomalies in the U.S. (World Health Organization., 2015; World Health 
Organization, 2015). This results in approximately 88,000 deaths, as well as 8.6 
million disability-adjusted life years, every year. A systematic review of 
international NTD occurrence reported national levels ranging from 0.3 -199.4 per 
10,000 live births from 1990-2014 (Zaganjor et al., 2016). Due to the role played 
by nutrition in their etiology (see below), increased rates of famine driven by 
conflict, population growth, and climate change will likely result in increased NTD 
incidence, particularly in low income countries where NTDs may account for 29% 
of neonatal deaths with observable causes (Blencowe et al., 2010). 
NTDs are the result of failures during embryonic development (Detrait et 
al., 2005; Jiang et al., 2011; Wallingford et al., 2013). Under normal conditions, 
the central nervous system starts as a flat sheet of cells, known as the neural 
plate, with paired neural folds develop along the rostrocaudal axis (Figure 1.1) 
During development, these folds roll and fuse to create a hollow tube containing 
the brain and spinal column (by day 28 in humans (O’Rahilly and Müller, 1994), 
E9.5 in mice). When this fusion fails to occur, parts of the CNS can become 
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exposed. The resulting defect can either be open to the environment, or, in rarer 
instances, enclosed by skin. Broad classification is primarily based on position: 
those defects occurring in the cranial region involving absence of the cranial vault 
and severe defects in the cerebral hemispheres are referred to as anencephaly, 
which is invariably fatal. If part of the brain or surrounding tissue is pushed 
through an opening in the skull, the condition is referred to as encephalocele. 
Defects that occur in the caudal portion of the neural tube are referred to as spina 
bifida, or meningomyelocele, and are the most frequently observed category 
(Zaganjor et al., 2016). Finally, defects over the entire body axis are referred to 
as craniorachischisis, and are also fatal. 
 
 
Figure 1.1. Neural Tube Closure. A. Successive images showing the 
progression of neural tube closure in a a stylize vertebrate embryo (rostral=up). 
B. Cross section illustrate closed (red) and open (regions) of the neural tube. C. 
Region-specific NTDs. Reprinted From Wallingford, 2013. 
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It is important to note that each of the above categories groups together a 
large number of specific phenotypic traits, and are not mutually exclusive. This is 
similar to the class of NTDs taken together- the name collects under one heading 
many different conditions. Partially for this reason, the etiology of NTDs is 
complex and multifactorial. Twin studies in mice have shown increased 
concordance in monozygotic twins compared to dizygotic twins (7.7% vs. 4.0%, 
(Deak et al., 2008)), indicating a heritable genetic component. However 
recurrence is only 2-5% in human families with two affected siblings (Sebold et 
al., 2005), demonstrating incomplete penetrance. Numerous studies of the 
genetics of NTDs have been published focusing on mutations in genes 
associated with folic acid metabolism, especially the rate limiting enzyme in the 
methyl cycle, MTHFR (Kirke et al., 2004; van der Put et al., 1995; Wang et al., 
2015). 
To date, no large-scale study whole genome study of NTD has been 
published, however sample collection and sequencing is ongoing among various 
national monitoring centers, such as the California Birth Defects Monitoring 
Program (CBDMP) (Croen et al., 1991). 
 
1.2  NTDs and Folic Acid Supplementation   
Maternal diet has also been shown to have a strong effect on NTD risk, in 
particular consumption of vitamin B9, or folic acid (FA). The Leeds observational 
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studies linked circulating levels of FA and other B vitamins in maternal blood to 
NTD risk, which were followed by successful interventional studies in preventing 
recurrence in mothers of NTD-bearing infants (Smithells, 1984; Smithells et al., 
1976, 1980, 1981). Further clinical studies found that maternal intake of FA 
reduced the incidence of NTDs by between 30-70% (Bower and Stanley, 1989; 
Mills et al., 1989; Mulinare J et al., 1988; Shaw et al., 1995; Werler MM et al., 
1993). In 1996, the US FDA introduced a FA fortifications program for staple 
cereal grains and flour (1996). Incidence of two forms of NTD, spina bifida and 
anencephaly, were reduced by 20% and 34% respectively, with greater declines 
being reported as a result of similar programs in Chile and Canada  (Wats et al. 
2007, Lopez-Camelo et al). Currently 80 countries around the world have 
implemented FA fortification programs, with a notable absence of such programs 
in European countries, excepting the United Kingdom. Governments may prefer 
education and voluntary dietary supplementation, as dietary folate is a naturally 
occurring nutrient found in foods such as leafy green vegetables, legumes, egg 
yolk, liver, and citrus fruit. They may also oppose universal fortification, for fear of 
potential side effects (Mills and Dimopoulos, 2015).  
Evidence for potential negative side affects of FA have come from several 
fronts. Among mice models of NTD, some show shift towards early embryonic 
lethality under FA supplementation (Gray et al., 2010). In vitro experiments have 
found that FA inhibits neurite extension synaptogenesis, and growth cone motility 
in chick embryos (Wiens, 2016). Finally, a Norwegian study of 6837 ischemic 
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heart patients (Ebbing et al., 2009), linked FA supplementation to increased risk 
of cancer (Hazard Ratio 1.21) and all-cause mortality (Hazard Ratio 1.18).  
 
1.3 FA and One-Carbon Metabolism 
The mechanism by which FA prevents NTDs has been an area of active 
and ongoing research (Blencowe et al., 2010; Ernest et al., 2002; Mills et al., 
1989; Molloy et al., 2017; Werler MM et al., 1993). Identifying said mechanism 
would both allay concerns about side effects of supplementation, while also 
potentially allowing for the design of alternative regimens. FA metabolism plays a 
central role in numerous cellular reactions through the one-carbon cycle (Bodnar 
et al., 2010; Greenberg et al., 2011; Suh et al., 2001). After being enzymatically 
reduced to tetrahyrafolate, it can be converted to L-methylfolate. L-methyfolate is 
biologically active, unlike FA or natural dietary folate, and it utilizes the supplied 
methyl (one-carbon) group in the synthesis of purines and pyramidines.  
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Figure 1.2 Folic Acid and One Carbon Metabolism. Reprinted from 
Greenberg et al., 2011 
 
1.4 DNA Methylation 
 DNA methylation describes the addition of methyl groups (CH3) to 
nucleotides within DNA, generally by specialized methyltransferase enzymes, 
such as DNMT1, DNTMT3A and DNMT3B in mammals (Lister and Ecker, 2009; 
Robertson and Wolffe, 2000). Such methylation is most frequently observed in 
cytosine, in particular those adjacent to guanine residues, i.e. CpG dinucleotides. 
Regions of the genome which are enriched for CpG dinucleotides are referred to 
as CpG islands, and are often co-located with promoters (Fatemi et al., 2005). 
Hypermethylation in the promoter region of a gene has been linked to decreased 
expression (Irizarry et al., 2009), through either direct prevention of 
transcriptional factor binding, or through recruitment of histones to create closed 
chromatin states (Hashimshony et al., 2003; Jones et al., 1998) . However more 
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complex relationships between methylation and expression have also been 
observed (Wagner et al., 2014). Methylated cytosines are also at a greater risk 
for mutation, as they can be deaminated into thymidine. It has been 
hypothesized that the silencing of retrotranspons may be a key evolutionary 
reason for the presence of DNA methylation, in accordance with viewing such 
elements as primarily genetic “parasites”, rather than having important 
functional significance (Yoder et al., 1997). 
 DNA methylation plays an important role in many vital biological processes 
such as embryogenesis (Smith et al., 2012), cellular differentiation (Beerman and 
Rossi, 2015), chromatin structure (Hashimshony et al., 2003), and imprinting (Li 
et al., 1993). Aberrant DNA methylation is widespread in cancer (Baylin, 2005) 
and linked to both disease initiation and progression (Portela and Esteller, 2010). 
Thus alterations of DNA methylation provides one pathway by which FA may be 
acting to prevent NTDs.  
The study of base modifications, of which methylated cytosine (5mC) is 
just one instance, has seen rapid advances in recent years. Ten-eleven 
translocation (TET) enzymes (Iyer et al., 2009) can further oxidized 5mc into 5-
hydroxymethycytosine (5hmC), 5-formlcytosine (5fC), and 5-carboxylcytosine 
(5caC), which can be recognized by base-excision repair mechanisms. Methods 
have been developed to detect each of these bases through chemical conversion 
(Booth et al., 2013) or immunological assays (Wheldon et al., 2014). 5hmC has 
been found at high levels in mouse embryonic cells (Szwagierczak et al., 2010), 
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while 5fmC has been found to have a highly tissue specific distributions during 
development, while 5caC may be a marker for active de-methylating processes.  
Another line of research has been into base modifications in RNA, particularly 
incorporation of N6-methyladenosine (m6A) (Fu et al., 2014; Lichinchi et al., 
2016),  which has been linked to numerous cancers. 
Figure 1.3 Dynamic of DNA Methylation Reprogramming in Mouse 
Embryos. a, Dynamics of 5mC and its oxidation products in pre-implantation 
embryos.. b, Illustration of the 5mC and 5hmC dynamics in primordial germ cells 
(PGCs) during their reprogramming.  Reprinted from Kohli and Zhang (2014) 
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During gamatogenesis and embryogenesis, DNA methylation patterns 
are erased and re-established in a process known as reprogramming (Figure 
1.3).  Reprogramming during embryogenesis involves initial demethylation of 
the paternal genome by TET enzymes, resulting in the increase of the 
downstream oxidative products 5hmc, 5faC, and 5caC (Gu et al., 2011b; Inoue 
et al., 2011; Wossidlo et al., 2011). Afterwards, global methylation levels for 
modified cytosines in both maternal and paternal genomes are reduced 
passively via replication (Inoue and Zhang, 2011), until being re-established at 
the blastocyte stage around E6.5 (Borgel et al., 2010; Smith et al., 2012). At 
this point, methylation is laid down throughout the genome, with differential 
patterning amongst cells leading to lineage restriction to certain tissue types (Ji 
et al., 2010; Mohn et al., 2008). In cells that have been selected to become 
primordial germline cells (PGCs), a more complex epigenetic program is 
observed at the epiblast stage, where demethylation occurs via non-oxidative 
processes (evidenced by unchanged levels of 5hmc), and then undergoing a 
second stage of oxidative demethylation. In the case of female embryos, one 
copy of the X chromosomes is randomly selected on a per-cell basis for 
genome-wide methylation resulting in inactivation of its constituent genes 
(Hellman and Chess, 2007; Mohn et al., 2008).  
Although DNA methylation is generally stable, it’s patterning does 
change with age (Ahuja and Issa, 2000), allowing the biological age of cells, 
tissues, and organisms to be inferred, in what has been referred to as the 
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“epigenetic clock.” In humans, a prominent example of such a predictor is 
Horvath’s clock, so named for Steve Horvath’s seminal study of methylation 
array data from 8,000 human samples including 51 tissue and cell types 
(Horvath, 2013). Horvath’s clock utilizes 353 CpG sites, selected via elastic-net 
regression from a pool of over 21,000 sites, and is predictive across tissues, 
irrespective of their specific methylation patterns, with a reported correlation of 
r=0.96, which similar correlations reported on independent datasets (Gibbs, 
2014). However, positive deviances in predicted epigenetic age from actual 
age, referred to epigenetic age acceleration, have been observed associated 
with Alzherimer’s disease (Horvath et al., 2015), Parkinson’s disease (Ritz and 
Horvath, 2015), and age-related macular degeneration (Lu et al., 2016). In 
general, lower levels of methylation are observed as an organism ages 
(Bjornsson et al., 2008). 
 
1.5 Lrp6-Based NTD Models and Wnt Signaling 
There are over 200 mouse models of NTD, however only 23 have been 
tested for their responsiveness to FA, and only 11 have in fact shown a positive 
effect (Harris and Juriloff, 2007, 2010). In particular, the curly tail mouse, the best 
studied model of spina bifida (van Straaten and Copp, 2001), is resistant to FA 
supplementation, though it can be rescued by inositol (Burren et al., 2010). The 
large number of potential candidates to study is indicative of the complexities of 
neurological development, with transcriptional differences being found along the 
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neural column during fusion, indicating specialized processes for each region 
(Colas and Schoenwolf, 2001; Copp and Greene, 2010; Wallingford, 2005; 
Yamaguchi and Miura, 2013).  
Our study focuses on two mutations in the Lrp6 (Low-density lipoprotein-
receptor related protein 6) gene, which provide NTD models with opposite 
responses to maternal FA. 
 
 
 
Figure 1.4 Model of Lrp6 Disregulation within the Cell. Under basal conditions, Lrp6 is 
efficiently trafficked and inserted into the cell membrane facilitated by MESD. The Cd mutation 
prevents Lrp6 interaction with MESD and leads to cleavage and defective processing of Lrp6Cd, 
all of which reduces localization of Lrp6Cd on the surface of the cell. The mutant Lrp6Cd 
accumulates within the cell to alter levels of β-catenin and increase GTP-RhoA levels through 
complexation with DAAM1. In the Lrp6−/− cells, only Lrp5 remains available for signal 
transduction, and it is insufficient to activate either the canonical or non-canonical pathways to the 
level necessary for proper neural tube closure. Reprinted from Gray, et al 2013
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Under basal conditions, Lrp6 is inserted into the cell membrane by MESD 
(Figure 1.4), and is a co-receptor for the Wnt (Wingless/Integrated) signaling 
pathway, which plays a critical role in neural development. Wnts are a family of 
secreted molecules that regulate numerous developmental events through 
several signal transduction pathways. Wnt signaling falls into three known 
pathways: the canonical pathway, the non-canonical planar cell polarity (PCP) 
pathway, and the non-canonical calcium pathway (Amerongen and Nusse, 2009). 
Lrp6 and Lrp5, along with their obligate co-receptor Frizzled (Frz) bind to axin in 
the presence of Wnt. The removal of axin from the cytosol prevents the formation 
of the beta catenin destruction complex, causing beta catenin to accumulate and 
be trafficked into the nucleus where it activates TCF/Lef transcription factors.  
Lrp6Cd  consists of a single point mutation in the extracellular domain of 
the Lrp6 protein (Carter et al., 2005). Heterozygotes display a crooked tail. In 
Lrp6Cd/Cd embryos, co-localization of Lrp6 into the membrane is reduced due to 
complexation with DAAM1, activating GTP-RhoA, while also causing build-up of 
beta-catenin in the cellular membrane, and reduced activation of TCF/Lef. 
Untreated, resulting defects include embryonic lethality, exencephaly  and runted 
pups with severe lumbosacral and tail deformities. However, maternal 
supplementation can enact a true rescue, with normal Mendelian distribution of 
genotypic ratios  (Gray et al., 2013). 
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In Lrp6-/- embryos, there is insufficient signal transduction to activate either 
the canonical or non-canonical wnt pathways for neural tube closure, and the 
embryos are not viable. Defects include body axis truncation, limb defects, eye 
and palate defects and a high incidence of exencephaly and/or spina bifida. 
Maternal supplementation with FA causes a shift towards early embryonic 
lethality and exencephaly, though as a percentage of live births NTD is reduced 
(Gray et al., 2010). Recent genetic studies in humans have linked Lrp6 mutations 
in humans to NTDs (Lei et al., 2015) and tooth angenesis (Ockeloen et al., 2016), 
making these backgrounds ever more attractive models. 
We hypothesized that the effect of FA on DNA methylation could contain 
information as to its phenotypic interactions with the Lrp6 Cd and null mutations. 
The most direct method by which this could be occurring would be epigenetic 
lesions caused by Lrp6 mutation status whose methylation levels were also 
effected by maternal FA, with corresponding changes in expression patterns in 
associated genes. For the null mutants, another possibility would be that 
downstream effects of the removal of Lrp6, in particular the reduction in TCF/Lef 
signaling, allow the addition of FA to disrupt the normal demethylation process 
during early embryogenesis. Such disruption, which would display itself as 
hypermethylation associated with increased maternal FA, could potentially be 
accompanied by increased expression of TET enzymes in order to compensate 
for the additional methyl groups. Such compensation would be expected 
relatively close to implantation to match the timeline set out by Kohli and Zhang. 
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A similar general mechanism could potentially explain the observations in 
the Cd background. This would be the case if the Cd mutation resulted in 
downstream interference with the reestablishment of methylation patterns prior to 
the epiblast developmental stage, with the additional FA compensating for this 
effect. If true, increased expression of DNMTs might be observed in the mutants, 
mirroring the hypothesis above in the nulls. However, the rescue of the crooked 
tail phenotype indicates a potentially much closer link between FA’s effects and 
Lrp6 biology. Increased methylation and decreased expression of one or more of 
the proteins the mutant Lrp6 protein complexes with, such as DAAM1, would be 
of particular interest.  
At the time the data for the samples was being collected, there was no 
published method for analysis of methylation data involving 2x2 or more complex 
designs as was needed for the study. This necessitated the creation of the 
multiDiff package (see below). In the discussion that follows, care must be taken 
to separate two separate uses of the word “interaction”. In a biological context, 
the word interaction generally implies some form of binding, or potentially some 
form of co-location. However, there is a separate mathematical notion of 
“interaction,” which refers to interaction terms in fitting a model. In brief, such 
interaction terms are usually the product of two other explanatory variables (i.e. 
C3=C1 * C2). As they are not a linear combination of other terms they do not 
generally cause any direct issues with model fitting. They correspond to non-
linearity in the data, and are appropriate when the effect of one variable mediates 
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the effect of the other, or when they both mediate each other. Hence the term 
“interaction”. Observation of a non-zero mathematical interaction indicates that 
the variables biologically interact at or upstream of the relevant data. The 
converse is not true- if the two individual biological effects “add together” when 
combined (see discussion of link functions in Chapter 2), then they may not 
require an interaction term. 
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CHAPTER 2 
 
Analyzing Methylation Data with Complex Designs 
 
 
2.1.  Assays for DNA Methylation 
Current studies of DNA methylation rely on two major classes of assays- 
those using microarrays, the most popular being the Illumina Infinium Human 
Methylation 450K BeadCHIP (Morris and Beck, 2015) and those using high-
throughput sequencing. Their strengths and weaknesses parallel the use of 
these platforms for detecting genomic variants. Arrays have the benefit of being 
lower cost, and consistently collecting identical sets of sites across samples. 
Sequencing based methods can be more challenging to analyze, due both to the 
increased amount of data and processing time, as well as the necessity of 
harmonizing sites across samples, while offering the potential to cover a larger 
number of sites. By examining the methylation patterning of specific reads, it 
also becomes possible to look for differences in combinatorial entropy at a given 
loci, an approach which has been used to detect changes in what have been 
referred to as epiallelles in leukemia patients (Li et al., 2014). 
Both the 450K Methylation arrays and NGS methods detect methylated 
cytosines by means of sodium bisulfite conversion. Sodium bisulfite converts 
unmethylated cytosines to uracils (Hayatsu, 2008), which are then treated as 
thymines during subsequent PCR reactions. For NGS data, specialized aligners, 
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such as BISMARK (Krueger and Andrews, 2011), BSMAP (Xi and Li, 2009), or 
RMAPBS (Smith et al., 2009), utilize in-silico bisfulfite treated version of the 
reference genome to align reads. Methylation levels can then be called from the 
resulting bam or sam file by comparing the number of C and T reads at each 
covered loci.  
Due to the time and expense of the conversion process, whole-genome 
bisulfite sequencing (WGBS) was, and remains, impractical for many studies. 
Reduced Representation Bisulfite Sequencing (Gu et al., 2011a; Meissner et al., 
2005) allows for a cost effective approach. By using the Mspl digestion enzyme 
to fragment DNA at C^CGG loci, and performing size selection, it is possible to 
collect data from CpG islands throughout the genome, and thus the promoters of 
most genes. An enhanced version of the protocol, eRRBS (Garrett-Bakelman et 
al., 2015), increases the number of covered loci and allows for coverage of sites 
further out from CpG islands, referred to as CpG shores.  
Methylation can be analyzed using binomial generalized linear modeling 
(see below). A common package for doing this is methylKit (Akalin et al., 2012) 
methylKit also allows use of DSS (Feng et al., 2014), a hierarchical Bayesian 
model using the beta-binomial, as well as the ability to control for covariates in 
the analysis. However, it currently lacks the ability to simultaneously analyze 
and visualize multiple covariates and their interactions. 
 
2.2 Introduction to Generalized Linear Models  
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 Generalized linear models (GLMs) are a class of statistical models used to 
analyze data that share an underlying distribution in a manner that generalizes 
the approach of standard linear regression (Agresti, 2015). In linear regression, 
one can write: 
(1)  Yi = β jXij
j
∑ +εi  
Where Yi is the feature being predicted in sample i, Xij are the j predictors of 
samples i, βj are the weights put on the features, and εi is the error for the ith 
sample. The appropriateness of the model can in part be assessed by how 
closely the errors, ε, actually follow a normal distribution with a single variance, 
σ2 and mean zero. Non-normality of the errors can potentially occur if the 
variance is not constant across the range of linear predictors XijBij, in a condition 
referred to as heteroscedastacity. In such a case, more complex models become 
appropriate. 
 We can reformulate the linear model in the following equivalent manner: 
 
(2)           
Yi ~ N(µi,σ 2 )
µi = β jXij
j
∑
 
  
Here, we are imagining the Yi’s being drawn from normal distributions with the 
same variance, but with means controlled by the remaining features/covariates. 
The equivalence can be seen in the independence of the mean and variance for 
the normal. In addition the range of the linear predictor (now defined as μ) is the 
	 29	
same as the range of the mean. In both formulations, we are also restricted to 
having the predictors having a linear effect on the mean. 
The first conceptual step for a GLM is to consider other distributions 
besides the normal from which the independent variable can be drawn. However, 
both of the previously mentioned properties- the mean with domain equal to the 
reals, and independence of the mean and variance, may fail to hold. For 
example, neither is true of the Poisson distribution, one of the most common 
distributions to model count data. It has mean and variance both equal to a single 
parameter, λ, which can be any positive real number. Thus, if we tried to set: 
(3)     
Yi ~ Poisson(λi )
λi = β jXij
j
∑  
 
We could potentially run into both limitations. It is theoretically possible for us to 
have a predicted mean less than zero, outside the allowable range. In addition, it 
would make little sense to try and use the original formulation of the linear model- 
with the error now Poisson distributed. it would be unable to have zero mean and 
non-zero variance in the stochastic part of the model, thus failing to capture the 
notion of error. 
 GLMs solve this problem by introducing what is referred to as a link 
function, generally noted as g. The link function serves the purpose of both 
mapping the domain of the distribution to the reals, and allowing more flexibility in 
related covariates to the mean. Thus we have the standard formulation of a GLM 
as: 
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(4) 
Yi ~ f (µi;σ 2 )
g(µi ) = β jXij
j
∑  
Here, f is a member of the exponential family of distributions, or potentially it’s 
extension, the over-dispersed exponential family (Chang et al., 2001; Gelfand 
and Dalal, 1990). Hypothesis testing is usually done with either a Wald test, 
which applies a chi-square test to each coefficient, or a likelihood ratio test, which 
compares the likelihood of the specified model to a reduced one with one or more 
terms removed. Another alternative is Rao’s score test, based on the score and 
Fisher information of parameter estimate can also be use. All three tests are 
asymptotically equivalent. For computational performance considerations, the 
Wald test was utilized in the analysis presented throughout. 
GLMs and their extensions have been applied to the analysis of many kinds 
of biological data, including microarray data (Smyth, 2004), differential 
expression (Anders and Huber, 2010) and splicing in RNA-seq (Anders et al., 
2012), DNA-methylation, neuronal spike patterns (Gerwinn et al., 2010). In the 
case of methylation data, we can set to f be the binomial distribution, and take 
the coverage as the (known) number of trials. Here, the link function must take 
the real line into the interval [0,1], which is done naturally by a sigmoidal function. 
The logit function, discussed below, is just such a sigmoid, and is the canonical 
link function for logistic regression. Other choices of link function may include the 
probit, log-complementary log (Agresti, 2015), or arcsine, discussed below. 
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2.3  Survey of published methods for base-resolution methylation data 
 
methylKit’s (Akalin et al., 2012) main functionality is built around a 
binomial GLM, a natural fit for binary response data (in this case methylated (C) 
and unmethylated (T) reads).  Other approaches have been implemented in 
various software packages for methylation analysis. In general, tradeoffs must be 
made between model complexity, runtime, ability to handle heteroscedasticity, 
and Type I and Type 2 errors. 
Instead of directly dealing with counts, some packages analyze the 
methylation ratio (methylated reads over coverage). These included Bsmooth 
(Hansen et al., 2012), IMA (Wang et al., 2012), Minfi (Aryee et al., 2014), 
COHCAP (Warden et al., 2013), CpGassoc (Barfield et al., 2012), and metilene 
(Jühling et al., 2016). For count-based methods, which thus retain information 
about coverage variability between samples, methylKit by default uses logistic 
regression, contrasting with RADMeth (Dolzhenko and Smith, 2014), MethylSig 
(Park et al., 2014), MOABS (Sun et al., 2014), DSS  (Feng et al., 2014) and DSS-
general (Park and Wu, 2016), which all use some form of beta-binomial 
regression. The beta distribution has support on the domain [0,1], and the 
variance of the distribution can be used to capture biological variability. A recent 
comparison of different methylation callers (Zhang et al., 2016), found that the 
ratio tests were not sensitive to small changes in methylation level, but that the 
beta-binomial implementations shared similar and superior performance. 
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2.4 Complex Designs and Assignment of Effect Sizes 
Most of the previously mentioned packages are designed to call 
differential methylation between only two group comparisons- only methylKit, 
RADMeth, and DSS-general are able to control for covariates or analyze more 
than one group. Of these, only DSS-general was created to analyze complex or 
general designs. In their initial paper (Park and Wu, 2016), they find what they 
believe to be unacceptable performance for pure logistic regression. However 
they do not directly simulate interaction terms, a key question when one has 
more than one effect of interest. Also they do not take up the problem of 
estimating effect size in logistic or beta-binomial regression. 
As has been increasingly appreciated (Sullivan and Feinn, 2012), 
statistical thresholds by themselves are generally insufficient when examining a 
large number of tests as is common in NGS datasets. A measure of effect size is 
vital to ensuring that to removing hypotheses that explain only miniscule amounts 
of the variation of interest.  
For logistic regression and its relatives, the standard effect size is the log-
odds of the regression coefficient. This corresponds to the fact that the log-odds 
changes by a constant factor when the linear predictor is moved by the 
corresponding amount. However, log-odds adds nothing to biological 
interpretability in the context of methylation data. Figure 2.1 illustrates this 
problem. Empirical estimates of methylation difference can be made in a 
straightforward manner with a single binary covariate, in despite of the fact that 
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the same coefficient value may have different empirical effects depending on the 
methylation level of the baseline condition. As each site is analyzed separately 
until correction for multiple hypothesis testing, there is no conflict. However, this 
becomes completely ambiguous when dealing with the case of two or more 
covariates being analyzed together at a single site. 
In order to solve this problem, we devised the maximum difference 
estimate. 
 
 
2.5 The Maximum Difference Estimate 
 
Let the input data consist of N CpG sites and D samples, with a design 
matrix X with J features after expanding interaction terms. For CpG site I (I = 
1,2,...N) in sample d (d =1,2…,D), let Yid and mid be the methylated and total read 
counts respectively.  At each site, logistic regression fits the unknown parameters 
βij data to the model: 
(5)     
Yid ~ Binomial(µid,mid )
logit(µid ) = βi0 + β jXij
j≥1
∑  
 
where logit is the function log(p/(1-p)),  βi0 is the baseline methylation at site I, 
and xd and βi are the dth row of the design matrix and ith row of the coefficient 
matrix. 
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From the estimates of the parameters β we define the maximum 
difference estimates for each term in the following manner. Let s be a binary 
vector with J entries, which we call a state vector. A particular s captures the 
patterns of effects operating at a given loci. Let sk be the indexed set of such 
vectors (k=1,2,...,2J). If we arranged the sk’s into a 2^J  by J matrix, they can be 
seen as equivalent to a binary truth table for J variables (Figure 2.1B).  
We define the maximum difference estimate for the jth predictor at site I, 
Mij as 
Mij = sgn(βij )•max1≤k≤2 j logit−1(βi0 + sk •βi )− logit−1(βi0 + sk •βi −βij )⎡⎣ ⎤⎦  
Effectively, we consider all possible states the site could be in, and compare the 
methylation levels with and without the factor of interest. We then use the state 
that maximizes the effect of the covariate to assign its effect size. We use the 
maximum due to the saturating nature of the sigmoidal curve, which by its nature 
makes it difficult to estimate multiple effects with small sample sizes as is 
common in bioinformatics studies. We also implement another methodology for 
those who wish to assign more conservative effect sizes, the mean difference 
estimate. Let Ldi  be the linear predictor for sample d at site i. Then we can assign 
the mean difference estimate, Aij, over the observed samples for factor j at site i: 𝐴!" = 1/𝐷 ∙ 𝑙𝑜𝑔𝑖𝑡 𝐿!" − 𝑙𝑜𝑔𝑖𝑡(𝐿!" − 𝛽!)!!!,,,!  
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Although the mean difference estimate has the benefit of making a clean 
empirical prediction on the data, it is inherently biased if sample sizes among 
cohorts are unequal.  
 Note that although the maximum difference estimate was defined above 
for logistic regression, it can be applied to any underlying model of the sigmoidal 
curve, i.e. any other link function. By it’s design it will tend to be relatively 
aggressive in assigning effect sizes, and will be sensitive to the region in the 
domain of the linear predictor that has the greatest dynamic response, which for 
standard sigmoids will be close to zero in linear space. 
 In the context of methylation analysis, we will refer to the maximum 
difference estimate as the maximum methylation difference (MMD) of an effect at 
a given loci.  
 
 
2.6 Benchmarking of False Positive Rate  
 
 
For our FPR analysis, we used GEO dataset GSE61163, which was utilized in 
Zhang et al (2016) in comparing differential methylation callers in the single 
binary factor context. The samples are from 39 individuals with chronic 
myelomonocytic leukemia (CML), whose tumors were sequenced with the 
eRRBS protocol before treatment. Following Zhang et al, we randomly selected 5 
subjects per cohort. The only alteration in the procedure was random assignment 
to four groups instead of two, imitating a 2x2 factorial design. Then both methods 
were run using the model: 
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Cov1 +Cov2 +IsBoth 
 , where IsBoth corresponded to an interaction term, i.e. IsBoth=Cov1*Cov2 
 This was done for 1000 trials, with a q-value of 0.01 used for all runs. Results 
are shown in Figure 2.1C & D. We observe that the maximum methylation 
difference threshold exhibit the ability to strongly control the FPR of multiDiff, 
dropping to less than one percent at an MMD threshold of 25% or greater. 
Notably, this thresholding had minimal effect on the already very low FPR of 
DSS. While demonstrating the power of controlling for biological variability, it is 
also indicative of the conservative results of utilizing beta-binomial models. 
 
2.7 Benchmarking of Accuracy. 
To benchmark accuracy, we followed a similar simulation procedure to the 
one outlined in the DSS-general paper, with some modifications. First, we added 
an interaction term to the simulation, since it was vital to ensure that our method 
could detect such interactions accurately. We then expanded the sites in the 
simulation by duplicating the baseline condition over eight chromosomes, each of 
which was associated with a single state vector for generating DMRs. This 
eliminated the need to specify the covariance of the effects within a given region, 
instead allowing us to assess the ability of a method to detect each possible 
differential state against the same background. Finally, we set the differential 
effect of the first covariate, where active, to be uniformly hypermethylating, the 
effect of Cov2 to be uniformly hypomethylating, and their interaction to be 
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uniformly hypermethylating. The result of applying this protocol to an artificially 
flat methylation landscape is depicted in Figure 2.2 A, with the percentage of 
differential sites in a region set to 100%. The null region/chromosome (no effects, 
i.e. s=(0,0,0)), is shown in the middle of the landscape. The control cohort has 
methylation identical to this null region across each chromosomes. The treatment 
cohorts have differential signal added as appropriate. 
Results are shown in Figure 2.3 for simulations using a sine link, and 
Figure 2.4 for those using logit link. Standard ROC curves are generated by 
varying p-value or q-value thresholds. Here we instead use varying MMD 
thresholds, after filtering by q-values <0.01, the standard cutoff, to demonstrate 
the value of . Each curve is the average of 20 runs. Simulations in the bottom row 
were down with differential effect sizes set to 10x the original parameters. In all 
combinations of parameters tested, multiDiff had a higher AUC. Taking all runs 
over all parameters, the difference in performance was statistically significant 
(p<2.2e-16, paired t-test). Thus, an effect size threshold can make performance of 
the binomial analysis comparable if not superior to that of beta-binomial 
 
 
2.8 Application of multiDiff to P2 Cd Male Dataset 
 
We applied multiDiff to a novel eRRBS dataset of Crooked tail mice. The 
Crooked tail (Cd) mouse is a model of neural tube defects that displays rescue 
under maternal supplementation of folic acid. Whole blood was collected from 16 
male animals in a 2 x 2 factorial design (Lrp6Cd/+ vs wildtype, 2ppm vs 10ppm FA 
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diet) design. In Table 2.1 we show the result of running the standard methylKit 
analyses to interrogate the effect of diet in each genotype, and then intersecting 
them, compared to running multiDiff on the data, with and without interactions. 
multiDiff without interactions is able to find ~2x more sites at the 25% threshold, 
and ~90x when the interaction term is included. The interaction term is 
associated with 70,924 sites at the 25% threshold, which are not possible to 
recover from the single factor analyses. To attempt to do so, one could take the 
symmetric difference of the sites found in each genotype. However, the 
cardinality of the symmetric difference is bounded above by the size of the union 
of the two sets, achieving that bound only when they are disjoint. in this example 
analysis, we could thus even at the theoretical maximum find only ~50% of 
interacting sites by analyzing each genotype separately. 
In Figure 2.5 we show the comparison of log p-values of the different 
analyses. Although there is an overall positive Pearson correlation between the 
wt and het values (, visually there appears to be a negative relationship. This 
appears due to the relative depletion of sites that are highly significant in both 
cohorts. Mathematically, such distinct effects are provided for by interaction 
terms, in this case the term Genotype:Diet. Biologically, thsThus comparing 
figure 2.6 A and B, we are able to see via inspection that there is enrichment for 
high p-values in the expected regions (up and to the right) when we fit the data 
using model with interactions, compare to without. 
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Figure 2.6 shows the standard visualizations of multiDiff output on the P2 
Cd Male dataset, covering over 1.3 million CpGs, with the MMD threshold set to 
25%, and q-value threshold set to 0.01, the standard settings. All loci that are not 
called as differential under the user’s statistical and effect size thresholds are 
removed by default. The heatmap is designed to be analogous to those for RNA-
seq. Each effect is shown in terms of a binary call matrix annotating the diagram, 
as well as the MMD associated with the effect in the heatmap proper. The violin 
and bar plots show the MMD distribution and number of DMCs at the input 
thresholds. 
 
2.9 Additional Comparison to DSS 
 
 We further investigated performance characteristics by analyzing the Cd 
mouse dataset with DSS, in both it’s single and general modes. The results are 
shown in Table 2.2. In single factor analysis, the DSS results were always a strict 
subset of the multiDiff results, with the number of hits for multiDiff even after 
MMD filtering more than an order of magnitude greater for both Wt and mutant 
animals. The only site that was called in all four analyses, before and after MMD 
thresholding, was in the exonic region of Egln2 (Egl-9 Family Hypoxia Inducible 
Factor 2). Egln2 is responsible for post-transcriptional modification of Hypoxia 
Inducible Factor (HIF), which is involved in oxygen homeostasis (Semenza, 
2001). In contrast, the 624 sites found by intersecting the binomial results, 
although still a fraction of those found when analyzing the full dataset together, 
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contained 32 DMCs in promoters, shown in Table 2.3. However, no significant 
pathway enrichment was detected in these sites, nor overlap with known wnt 
signaling genes. 
No overlap between the methods was observed in the either the simple 
two factor model (Diet+ Genotype), or the model with interactions (Diet + 
Genotype). After controlling for effect size, all of the hits produced by DSS were 
filtered out in the more complex analyses. We believe this to indicate that beta-
binomial regression may be too conservative in such settings with relatively low 
sample sizes. 
 
2.10 Conclusion 
 
multiDiff, implementing the maximum difference estimate, is able to control 
the normally high FDR associated with logistic regression, and displays superior 
AUC performance to an alternate method for analyzing complex methylation 
designs.
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Table 2.1. Comparison of multiDiff output to intersection of standard methylKit analyses. 
Methylation Difference is the empirical difference in the group means for the single factor 
analysis, MMD for Multi-factor. q-value cutoff was 0.01. 
 
Table 2.2. Comparison of multiDiff and DSS output on Cd Male Dataset. Numbers are the 
number of DMCs called associated with diet. Diff. is the empirical difference in the group means 
for the single factor analysis, MMD for Multi-factor. The sole site found in the intersection of the 
Single Factor analyses is in the exonic region of Egln2.  
 
Nfia,Pinlyp,Slc9a9,Klhl38,Hs3st2,Ino80e,Gm13003,Denr,Fap,Col18a1,Pdzd7,Myh14,Ptgds,Fcgb
p,Mydgf,Popdc2,Zrsr1,Alpk3,Nhsl2,Apcdd1,Gnat2,Frk,Psma8,Ltk,Ddx4,Sema3b,Dock2,Ehf,3110
099E03Rik,Gm16287,Frmpd1os,5830416I19Rik 
 
Table 2.3 . List of genes with FA-associated DMCs in promoter regions in Lrp6 Cd and Wt 
Embryos. DMCs were intersected from the single factor methylKit analysis, MMD>25%  
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Figure 2.1 Effects and Effect Sizes in Logistic Regression. A. Similar distributions of data 
can be readily assigned a biologically meaningful effect size in terms of methylation when 
originating from different sites, but do not admit ready interpretation with multiple factors. B 
Binary state vectors capture the combination of effects acting on a given locus. The set of 
state vectors can be arranged to form a truth table over possible effects.
sk	 G	 D	 I	
(1,1,1)	 ↔	 T	 T	 T	
(1,1,0)	 ↔	 T	 T	 F	
(1,0,1)	 ↔	 T	 F	 T	
(1,0,0)	 ↔	 T	 F	 F	
(0,1,1)	 ↔	 F	 T	 T	
(0,1,0)	 ↔	 F	 T	 F	
(0,0,1)	 ↔	 F	 F	 T	
(0,0,0)	 ↔	 F	 F	
	
F	
Sample	ID	 Gender	 Diet	 Interac2on	
Female_Control_1	 0	 0	 0	
Male_Control_1	 1	 0	 0	
Female_Diet_1	 0	 1	 0	
Female_Diet_1	 1	 1	 1	
Design	Matrix,		Xij	
G=Gender	Has	Eﬀect	
D=Diet	Has	Eﬀect	
I=Sex:Diet	InteracFon	Has	Eﬀect	
State	Vectors	
j=3	Features	
8	=2j	
States	
	d	sam
ples	
Single	Factor,	
	Mul1ple	Sites	
Mul1ple	Factors,	
	Single	Site	
A	
B	
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Figure 2.2 FPR Benchmarking Simulations. A. Simplified methylation landscape, with each 
chromosome corresponding to a region where a different set of effects is active. B. Raw 
methylation signal on random subsample of the CML cohort  C. Plot of confidence intervals of 
FPR over 100 trails. D. Inset showing performance when the Maximum Methylation 
Difference (MMD) threshold goes from zero to 25%.
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Figure 2.3. Comparison of multiDiff and DSS, simulating with sine link. Top row is simulated 
using effect size reported in Park and Wu 2016, bottom row has effect sizes increased by 10x. 
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Figure 2.4 Comparison of multiDiff and DSS, simulating with logit link. Top row is 
simulated using effect size reported in Park and Wu, 2016, bottom row has effect sizes 
increased by 10x.
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A.  	B.
	
Figure 2.5 Comparison of Single Factor and Pooled P-Values. A. Log p-values for the Wt 
and Cd mutants, colored by the log p-values in the analysis of the pooled data without the 
interaction term Genotype:Diet . B. Log p-values for the Wt and Cd mutants, colored by the 
log p-values in the analysis of the pooled data run with atheinteraction term.
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Figure 2.6 Visualization of multiDiff output for P2 Cd Male Dataset. DMCs called with 
q<0.01, Maximum Methylation Difference > 25
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CHAPTER 3 
 
Analysis of FA Action in Lrp6 NTD Models 
 
 
3.1 Potential Mechanisms of FA Action 
 
We hypothesized that changes in DNA methylation due to FA 
supplementation were key to understanding the effect of FA on Lrp6 Cd and null 
mutants. Three more specific hypotheses are depicted in Figure 3.1, illustrating 
different potential models of FA action, and their associated patterns of 
methylation. Since the same classification scheme can be applied to expression 
data, we consider both within the same framework. 
In the additive model, both the FA and Lrp6 mutation affect the observed 
level of a fixed marker (either percent methylation at a loci or expression of a 
transcript). These effects persist and additively combine when the interventions 
are paired. In the independent model, FA and the mutations operate at distinct 
loci, and their interactions occur downstream of the observed marker. Therefore 
the critical markers underlying FA’s effect are not necessarily associated with a 
genotype-driven change. However, FA’s effect continues to be observed under 
the mutation condition. Finally, in the combinatorial model, both FA and the 
mutation must be present to create a differential effect. This suggests an 
interaction upstream of the marker being observed. The combinatorial model can 
	 50	
Figure 3.1. Potential Mechanisms of FA Action. In the Additive model, both FA and 
mutation status affect the given marker, and their effects add together when both are 
present. In the Independent model, FA and the Lrp6 mutation are affecting distinct loci or 
transcripts, and interact downstream when present together. In the Combinatorial model, 
the critical loci are only affected when both FA and the mutation are present
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be described as either a Lrp6-dependent effect of FA, or an FA-dependent effect 
of Lrp6 status, but here they are mathematically equivalent. 
To investigate the evidence for these different models, we performed 
enhanced reduced representation bisulfite sequencing (eRRBS) to profile DNA 
methylation at base-level resolution and RNA-seq, both assays on Embryonic 
day 9.5 (E9.5) Lrp6 knockout (KO) or Lrp6 Cd mouse lines.. We gathered 
heterozygous mutants and wildtype siblings whose dams had been fed either 
control (2ppm) or FA supplemented (10ppm) diets  (Carter et al., 1999; Gray et 
al., 2010). E 9.5 was chosen as this corresponds to the end of neurulation. 
Heterozygous animals were used so that embryos could be appropriately 
developmental-stage matched for somite count and to permit comparison with 
postnatal ages, as Lrp6-/- are non-viable. We additionally performed eRRBS on 
whole blood from P2 mice to look for evidence of sites with persistent changes in 
methylation associated with maternal FA supplementation and mutation status. 
These could prove to be useful biomarkers with applications to NTDs human.  
The design of the full dataset is shown in Table 3.1.  
3.2 Maps of Differential Methylation 
 Figure 3.3 shows the maps of differential methylation in both backgrounds 
without regard to mechanism. We observe that in both backgrounds the largest 
number of loci is affected by maternal FA, followed by mutation-FA interactions, 
and last the mutations themselves. However, in the Cd background, FA’s effect 
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had a strong bias towards increasing methylation throughout the genome, even 
when it wasn’t called as having an effect, with the exception of chrX. On the KO  
background, FA’s distribution of effects were more strongly bimodal, with some 
bias towards hypomethylation.  
	
Table 3.1 Summary of Lrp6 NTD Mice Model Dataset. Counts are those after outlier samples 
were identified and removed during exploratory analysis 
 
3.3.1 Analysis of FA Mechanisms in Cd Background 
Results of genic annotation of differentially methylated cytosines and 
differentially expressed genes (DEGs) assigned  by mechanistic classification are 
seen in Table 3.3. We refer to the annotated genes from the methylation analysis 
as differentially methylated genes (DMGs) No overlap was found between the 
DEGs (q<0.05, |LFC|>0.5), and DMGs in the Cd background for any of the 
mechanisms. 
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Associated with the independent mechanism was enrichment (using 
STRING DB (Szklarczyk et al., 2017))  amongst the DEGs for housekeeping 
pathways in the nucleus such as regulation of nucleobase-containing compound 
metabolic process (fdr=4.28e-5) and gene expression (fdr=6.05e-5) (Table 3.2). 
There was no observed enriched pathway in the DMGs.  
Since FA rescues Cd mice, we looked for connection between Lrp6 and 
the lists of DEGs and DMGs by submitting them to StringDB along with the 
following list of Lrp6-associated genes:  Ctb1, Daam1, Lrp6, Lrp5, Dvl1, Rhoa, 
Arhgef19, Mesdc2, Frzb, Axi, and observed which if any genes were found to 
have connections to this input set. Among the DMGs, only S1pr4, which is 
involved in cell migration shared a link to Lrp6 via RhoA. Similarly, the DEGs 
Crtc1, Dot1l, Dvl3, Dyrk1b.,	Gli2,	Mll2, Myh11,and Hipk2 are connected to wnt 
signaling and Lrp6 as can be seen in Figure 3.3. Dvl3 shares strong similarity to 
Dvl1, which is normally recruited by Lrp6 to the plasma membrane. Hipk2 is part 
of a digenic NTD model of exencephaly with Hipk1 (Isono et al., 2006). 
3.3.2 Analysis of Combinatorial Mechanisms in Cd Background 
More DEGs were found associated with the combinatorial mechanism (91)  
than the independent mechanism (46). Once, again, known NTD gene Hipk2 and 
Dvl were found to be differentially expressed associated with the combinatorial 
mechanism. Zic3 is also known to be an NTD gene (Carrel et al. (2000); Klootwijk 
et al. (2000); Purandare et al. (2002); Lickert et al. (2005)) however it’s location on 
chrX meant that it’s signal was highly confounded with sex differences.
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Figure 3.2 Differential Methylation in Lrp6 Cd KO Background. Top Row: MMD 
Heatmap of effects with differential calls of loci indicated at top of figure. Middle Row: Violin plots 
showing MMD distribution for each effect. Bottom Row: Number of DMCs associated with each 
effect
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Figure 3.3 Analysis of Differentially Expressed Genes, Cd Background.  A. Heatmap of Log2FoldChange, Cd 
Background. B. Combinatorial DEGs Associated with Wnt Signalng C. Independent DEGs Associated with Wnt 
Signaling!
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Table	3.1	Genes	Assocaited	with	Mechanisms	of	FA	Ac;on	in	
Cd	Background	
Table 3.2 Genes Associated with Mechanisms of FA Action in Cd Background!
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3.3.3 Discussion of Mechanisms in Cd Background 
 The data does not support the additive mechanism at all in the Cd strain, 
but there does not seem to be evidence that both the independent and 
combinatorial mechanisms are active. Most interestingly, even when it doesn’t 
pass the threshold to be significant, the interaction between the diet and mutation 
is ever present, slightly repressing expression. The simplest interpretation for the 
main effect of the diet is the additional carbon is being used to counteract the 
known and observed hyperactivity associated with the Cd mutation through 
silencing. However, this does not explain the mechanisms driving the interaction 
effects. 
 There are only 5 genes up-regulated by the FA:Cd Interaction. The second 
ranked is Folh (Folate Hydrolase, LFC=0.665). Folh1 acts as a glutamate 
carboxypeptidase on folate, and is known to be expressed in the central and 
peripheral nervous system. It appears to be a good candidate for follow up study. 
If it is playing a role in FA rescue, then the initial hypothesis would that it is 
playing a role in trafficking beta catenin into the nuclease, directly by some form 
of recruitment, or indirectly, by activation of the actin destruction complex. Also of 
interest is Hesx1 (LFC=0.5342759),  a homeobox gene which is a transcriptional 
repressor in the developing forebrain (Dattani et al., 1998). The other up-
regulated interaction genes are: Fam167a (LFC=0.676), Pla2g7, (LFC=0.117), 
and Lrrn4 (LFC=.403). 
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Figure 3.4 Differential Methylation in Lrp6 KO Background. Top Row: Heatmaps of Max. 
Meth Difference Estimates, with differential calls of loci in black on top. Middle Row: Violin plots 
showing distribution of Max. Meth Difference Estimates for each effect. Bottom Row: Number of 
DMCs associated with each effect
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3.4 Analysis of FA Mechanisms in Lrp6 KO 
 
Results of genic annotation of sites assigned by potential mechanism are 
seen in Table 3.3. Rn45s, a pre-ribosomal protein was found to both be 
differentially methylated and expressed under the independent mechanism, and 
has been reported to be differentially methylated in the brains of mice perinatally 
exposed to lead. (Sánchez-Martín et al., 2015). Ubql2 has been found to be 
associated with amyotrophic lateral sclerosis and dementia (Deng et al., 2011). 
By far the largest number of genes (703), were associated with differential 
expression under the independent mechanism. These are shown in Table 3.4. 
Enriched KEGG Pathways were Systemic lupus erythematosus 
(FDR=0.0009160), Metabolic pathways (FDR=0.0106), and Alcoholism 
(FDR=0.0106). The set was also enriched for histone domains H2A/H2B/H3/H4 
(FDR=1.87e13) 
Mechanism Additive Independent Combinatorial 
Differentially 
Methylated 
Genes 
(DMC in First 
Exon or >3 in 
Promoter, 
multiDiff: 
q<0.01, Max. 
Meth Diff>25) 
Ubqln2 
Rn45s 
1700018B24Rik,AA
414768,B630019K0
6Rik,Chst7,Gm877
3,Gsc,Ppp1r3fos,R
n45s,Rnf113a1,So
wahd,Spin4,Ubl4a,
Ubqln2*,Zfa-
ps,Zic3,	
 
1110012L19Rik,1700018B24Rik,AA414768,B63
0019K06Rik,Chst7,Crk,Cx3cl1,Gm16617,Gpr50,
Mirlet7c2,Mospd4,Ndufb11,Ppp1r3fos,Ptchd1,R
ai2,Rbm3os,Rn45s,Rnf113a1,Slitrk4,Sowahd,Sp
in4,Ubqln2,Zic3, 
 
Differentially 
Expressed 
Genes 
(Deseq2: 
abs(lfc)>0.5, 
qvalue<0.05) 
- 703 genes - 
Intersection - Rn45s - 
 
Table 3.3 Genes Associated with Mechanisms of FA Action in KO Background.
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Differentially Expressed Genes Assoc. With Independent Mechanism of FA 
Action in Lrp6 KO Mice 
0610010K14Rik,1110001J03Rik,1110007C09Rik,1110008J03Rik,1110065P20Rik,1700037C18Rik,1810019J16Rik,2010
001M06Rik,2010320M18Rik,2310003H01Rik,2310011J03Rik,2310045N01Rik,2310067B10Rik,2610305D13Rik,2810428I
15Rik,4930432K21Rik,5730408K05Rik,8430429K09Rik,9130017N09Rik,9430076G02Rik,A230056P14Rik,A430005L14R
ik,A530016L24Rik,AI413582,Aacs,Aamp,Aatk,Abcc10,Abhd16a,Abhd17a,Abhd8,Abtb1,Acaa1a,Acads,Acsf3,Acta1,Actn3
,Actr5,Acy1,Adam23,Adc,Adck5,Adprhl2,Adssl1,Aes,Agap2,Ahdc1,Akr1e1,Akr7a5,Aldh16a1,Alkbh2,Anapc13,Ankrd23,An
ks6,Ano8,Ap5z1,Apba2,Apba3,Apbb1,Apc2,Aprt,Arhgef10l,Arl10,Armc6,Arrdc1,Arvcf,Asb2,Asb6,Asic4,Atg2a,Atg4d,Atoh
8,Atp13a2,Atp5g1,Atpbd4,Atxn7l2,Azi1,B3gat3,B930041F14Rik,BC005764,Bai2,Baiap2,Bcam,Bcat2,Bckdha,Bcl7c,Beta-
s,Bola2,Brat1,Btbd2,Cacnb3,Cactin,Capn10,Car11,Car2,Card10,Caskin2,Casr,Cc2d1a,Ccdc106,Ccdc124,Ccdc22,Ccdc6
4b,Ccdc8,Ccdc85c,Ccdc88c,Ccnb1ip1,Ccrl1,Cd14,Cd4,Cdc42ep1,Cdk2ap2,Cdk5rap3,Cep170b,Chkb,Chpf,Chrd,Chtf18,
Cited2,Ckb,Cldn4,Clec2l,Clgn,Clpp,Cntrob,Col18a1,Col2a1,Cope,Coro7,Cox6b2,Crip1,Crip2,Crocc,Csf2ra,Csnk1g2,Csrn
p1,Ctu2,Cuedc2,Cul7,Cul9,Cx3cl1,Cyb561,Cyp26c1,D2Wsu81e,D330041H03Rik,Dak,Dalrd3,Dapk3,Dbp,Dcaf15,Dctn1,D
cxr,Dda1,Ddah2,Ddn,Des,Dhx34,Dhx38,Dnalc4,Doc2g,Dohh,Dos,Dpm3,Dpysl4,Drap1,Dtx2,Dus3l,Dvl2,E030030I06Rik,E
130309D14Rik,E4f1,Ecsit,Edf1,Eef2,Efs,Egln2,Ell2,Emilin1,Eml2,Emp3,Engase,Enho,Eno1,Eno3,Ephb3,Ephb6,Ercc1,Erf
,Esrra,Etfb,Evpl,Exoc3l4,Exosc5,Eya2,Fam129c,Fam131a,Fam173a,Fam181a,Fam195a,Fam195b,Fam69b,Fam83h,Fan
ce,Fasn,Fastk,Fau,Fbf1,Fbxl18,Fbxl6,Fbxo31,Fbxw9,Fcho1,Fdxr,Fes,Fgd2,Fitm1,Fkbp8,Flot1,Flywch2,Foxi2,Frzb,Fsd1,F
tl1,Fzr1,Galk1,Gamt,Gatsl3,Gck,Gcn1l1,Ggt7,Gins2,Gipc1,Gjb3,Gli1,Gm13154,Gm13212,Gm16119,Gm1943,Gm4349,G
mppa,Gnaz,Gnb2,Gnl1,Gpaa1,Gpr137,Gpr162,Gpr179,Gpt,Grcc10,Grrp1,Gstp1,Gstt2,Gtpbp6,Gtse1,Gypa,H60b,Haghl,H
ap1,Hapln3,Hbb-
bh1,Hdac5,Hdgfrp2,Hecw2,Hes5,Hhipl1,Hip1r,Hist1h1c,Hist1h1d,Hist1h2ak,Hist1h2bc,Hist1h2be,Hist1h2bf,Hist1h2bg,Hi
st1h2bh,Hist1h2bj,Hist1h2bk,Hist1h2bl,Hist1h2bm,Hist1h2bn,Hist1h2bp,Hist1h3a,Hist1h3b,Hist1h3c,Hist1h3d,Hist1h3e,H
ist1h3f,Hist1h3g,Hist1h3h,Hist1h3i,Hist1h4a,Hist1h4b,Hist1h4c,Hist1h4d,Hist1h4f,Hist1h4h,Hist1h4i,Hist1h4j,Hist1h4k,His
t1h4n,Hist2h2ac,Hist3h2a,Hist3h2ba,Hist4h4,Hmg20b,Hmgn5,Hmha1,Hook2,Hps1,Hps4,Hspb7,Hspbp1,Hyal2,Hyal3,Ier2
,Igsf9,Igsf9b,Ikzf1,Ints1,Irs2,Irx1,Isg15,Isoc2a,Isyna1,Itga3,Jag2,Josd2,Jph2,Jrk,Kank3,Kazald1,Kcnj14,Kdm4b,Kel,Kif2a,
Kifc5b,Klhl17,Klhl36,Klk8,Krt19,Lamb2,Lars2,Lemd2,Leprel2,Lipe,Llgl1,Llgl2,Lmna,Lmnb2,Lmtk3,Lpcat2,Lrfn4,Lrp6,Lrrc1
6b,Lrrc29,Lrrc45,Lrrc4b,Lrrc56,Lzts2,Man2c1,Map1lc3a,Map2k2,Map3k10,Map3k11,Map3k14,Map4k2,Mapk13,Mapk8ip1
,March9,Mbd3,Mblac1,Mcf2l,Mcrs1,Mdfi,Mdk,Med16,Meis3,Metrn,Mettl21d,Mettl22,Mfap2,Mgmt,Mib2,Mier2,Miip,Mipol1,
Mir5109,Mlycd,Mocs1,Mpnd,Mpv17l2,Mroh1,Mrpl12,Msto1,Mus81,Mvd,Mvk,Mybpc3,Myh14,Myh7,Myh7b,Myl1,Myl3,Myl4
,Myl6,Myl7,Myo18b,Myo7a,N4bp3,Naa10,Nacad,Nacc2,Naglu,Nat6,Nat8l,Nat9,Ncdn,Ncln,Ndufa11,Ndufb7,Ndufs7,Ndufs
8,Neurl2,Nfatc4,Nkiras2,Nkx6-
2,Nle1,Nol12,Nosip,Nphp4,Nppa,Nppb,Nr1h2,Nrip3,Nt5c,Nthl1,Nudc,Nudt14,Nudt22,Nudt8,Nxpe2,Nxph3,Ogdhl,Oxsm,P4
htm,Pacsin3,Pafah1b3,Palm,Pcbp4,Pcif1,Pdgfa,Pex14,Pex16,Pex6,Pfkl,Pgls,Phb,Phf15,Phldb1,Pick1,Pih1d1,Pik3cd,Pkd
cc,Pkhd1l1,Pkmyt1,Pkn1,Pkn3,Pla2g6,Plcd1,Pld3,Plec,Plekhm2,Plekho1,Pmm1,Pnkp,Pofut2,Pold2,Poll,Polr2e,Polr2f,Pol
r2i,Pop7,Ppan,Ppdpf,Ppp1r14b,Ppp1r16a,Ppp1r37,Prdx5,Prelp,Prex1,Prrg2,Prrx2,Psmb10,Psmd3,Psmg3,Ptov1,Ptprs,Pu
s1,Qtrt1,Rabac1,Rabep2,Rac3,Rai1,Ralgds,Rapgef3,Rara,Rarres1,Rcn3,Rcor2,Rexo1,Rfx1,Rhag,Rhbdd3,Rhbdf1,Rhpn1
,Rims3,Ring1,Rmrp,Rn45s,Rnaseh2c,Rnf126,Rnf220,Rnf31,Rnu12,Rpl11,Rpl27,Rpl28,Rpl34,Rpl35,Rpl36,Rpl38,Rpl8,Rp
ph1,Rprl3,Rps15,Rps15a-ps4,Rps15a-
ps6,Rps16,Rps19,Rps26,Rps3a1,Rps7,Rps9,Rpusd1,Rrp9,Rtbdn,Rtkn,Ruvbl2,Rxrb,Saa1,Sars2,Sbf1,Sbno2,Scarf1,Scarf
2,Scoc,Scrib,Scrn2,Sema5b,Setd4,Sgsm2,Sh3gl1,Sh3glb2,Shank1,Shd,Sirt6,Sirt7,Skiv2l,Slc12a9,Slc25a10,Slc25a22,Slc
25a38,Slc25a42,Slc26a10,Slc2a8,Slc30a10,Slc35c2,Slc35e4,Slc39a3,Slc39a8,Slc4a3,Slc9a3r2,Snora17,Snora78,Sox3,S
phk2,Spint2,Sppl2b,Spry1,Spsb2,Spta1,Src,Srf,Ssbp4,Ssh3,Sssca1,Stk19,Stoml1,Sugp1,Svopl,Syne4,Sypl,Syt3,Tab1,Ta
da3,Taf1c,Taldo1,Tarbp2,Tbc1d10a,Tbx1,Tcf3,Telo2,Tesc,Tesk1,Tff3,Tfip11,Thap7,Thop1,Timm13,Tjp3,Tk1,Tmem121,T
mem132a,Tmem134,Tmem143,Tmem160,Tmem205,Tmem219,Tmem56,Tmtc3,Tnks1bp1,Tnni1,Tnni3,Tomm40,Tor2a,T
pgs1,Tppp3,Tpt1,Trabd,Traf4,Trappc9,Trim46,Triobp,Trmt61a,Trp53i11,Trp53i13,Trpv2,Tsen34,Tsen54,Tssc4,Tssk6,Twf
2,Txnip,U2af1l4,Ubb,Ubtd1,Ulk4,Unc45a,Unk,Upk3bl,Uqcr10,Uqcr11,Usp19,Vill,Vps18,Wbp1,Wdr18,Wdr24,Wdr25,Wdr3
4,Wdr6,Wdr65,Wdr86,Wdr90,Wdtc1,Wnt4,Wtip,Xab2,Xk,Ydjc,Zbtb12,Zbtb17,Zbtb48,Zdhhc1,Zfand2b,Zfp13,Zfp219,Zfp41
4,Zfp459,Zfp523,Zfp574,Zfp651,Zfp653,Zfp668,Zfp688,Zfp707,Zfp710,Zfp97,Zfpl1,Zfyve28,Znhit2,Zscan10,Zscan25,Zswi
m4, 
Table 3.4 Differentially Expressed Genes Associated with Independent Mechanism of FA 
Action in Lrp6 KO Background.  Independent genes were defined as those with q<0.05, 
abs(LFC)>0.5 under the 10ppm/2ppm contrast.
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3.5. Persistent Biomarkers of FA and Lrp6 Mutation Status 
 
 As previously discussed, “neural tube defects” is an umbrella term that 
groups many distinct syndromes under a single heading, ranging from inevitably 
lethal conditions such as exencephaly, to others that may have no noticeable 
impact on health and can easily go undiagnosed, such as in spina bifida 
occuluta, which as the name implies is often hidden. Nevertheless, if biomarkers 
can be found that correlate with NTD status, both parents and caregivers can be 
better prepared for the full range of outcomes, and be given the opportunity to 
intervene at an earlier stage. Proteomic analysis has been able to identify ADP-
ribosylation factor 1, a protein similar to cold agglutinin FS-1 antibody light-chain, 
vitamin K3 protein  and another unknown protein as biomarkers of NTD status in 
expecting mothers, with a 90 
 Ongoing advances in biotechnology are making it possible to extract and 
sequence fetal genetic material from circulating blood (Kitzman et al., 2012). 
Utilization of handheld DNA sequencers, such as the MinION from Oxford 
Nanopore (Jain et al., 2016), which are already capable of detecting base 
modifications, may soon allow for the assaying of fetal methylation levels on an 
ongoing basis. The combination of biomarkers with such a monitoring system 
could be a powerful tool, and the ability for such assessments to be done non-
invasively could lower costs and improve quality of care. 
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3.6. P2 eRRBS Dataset 
 
 As shown in Table 3.1, whole blood from P2 mice on both mutant 
backgrounds was collected, with mothers fed control (2ppm) or elevated (10ppm) 
amounts of FA. Extraction and data analysis was performed as previously 
described. Samples were collected and sequenced in three groups. Lack of batch 
of effects was confirmed using visual inspection of clustering and PCA analysis.  
 
3.7 Filtering of CpG’s Associated with Tissue/Developmental Differences 
 
 It is well known that DNA methylation has tissue–specific patterning (Chen 
et al., 2016; Lehmann-Werman et al., 2016; Lokk et al., 2014). In addition, it has 
been shown that methylation data can be used to accurately estimate the age of 
a sample- though it can also be used to estimate a separate quantity, “epigenetic 
age” that may match or diverge from chronological age. Such differences 
complicate direct comparison between the methylation data in the embryonic and 
P2 samples. 
To control for these differences, cross-timepoint cohorts were constructed 
for each background, with all Lrp6 mutants removed. These control cohorts used 
only wildtype mice on the control diet, while controlling for gender and gender-
specific tissue differences by running multiDiff with the following model: 
Tissue (P2/E9.5) + Gender (Male/Female) + Tissue:Gender 
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 After filtering both sites associated with primary and gender specific tissue 
differences, 87% (546,389 sites) of embryonic sites were retained on the Cd 
background, while 90% (559,937) of sites were retained on the KO background 
 
3.8 Analysis of Persistent Methylation Across Time Points 
 After following the filtering procedure previously described, the remaining 
differential sites at each timepoint were intersected. The results can be seen in 
Table 3.4. Larger numbers of sites were found to be associated with persistent 
effects of FA diet than either mutation. After annotation to the nearest gene, no 
genes with more than a single persistent DMC were found in the Cd background 
for either effect. In the KO background, Rn45s and Fktn were persistently 
associated with  FA. The Fktn gene encodes a type II transmembrane protein 
that is targeted to the Golgi apparatus through an N-terminal signal 
anchor(Esapa et al., 2002), and has been linked to lissencephaly( Deak et al., 
2008; Puckett et al., 2009), a condition where parts of the brain appear smooth. 
 Rn45s was previously discussed as the sole gene showing differential 
expression and differential promoter methylation associated with the independent 
mechanism of FA action. Neither Fktn nor Rn45s show significant changes in 
expression related to diet  (q-values:0.78, 0.40, LFC: 0.208254, -0.0987), or diet-
genotype interactions at E9.5.  
 
3.9  Pathway Analysis of Persistently Methylated Genes 
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 In the Cd background, persistent methylation associated with dietary FA 
was significantly enriched for reproductively and sex associated developmental 
pathways (Figure 3.5). We speculate this may be a partial artifact of the gender 
imbalances in the cohort, or potentially be linked to the known elevation of NTDs 
in female mice. On the other hand, the genes associated with the Cd mutation 
are only enriched for dendritic function.  (fdr=0.03), This is quite intriguing, and 
may provide  basis for hope of a novel biomarker if it can be found to match 
human data. The associated genes with dendritic function are Max, Espn, Ephb1, 
Anxa3, Cabp1, Kif21a. 
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Figure 3.5 Pathway Analysis of Genes with Persistent DMCs Assoc. with FA. On Cd 
Background.  Persistent genes were defined by annotating the intersection of differential sites 
associated with FA at E9.5 and P2. Visualization and enrichment analysis performed using 
STRING. 
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Figure 3.6 Pathway Analysis of Genes with Persistent DMCs Assoc. with Cd Mutation 
On Cd Background.  Persistent genes were defined by annotating the intersection of differential 
sites associated with Cd mutation at E9.5 and P2. Visualization and enrichment analysis 
performed using STRING. 
 
 
 
 
 
Figure 3.7 Pathway Analysis of Genes with Persistent DMCs Assoc. with Lrp6 KO. 
Persistent genes were defined by annotating the intersection of differential sites associated with 
Lrp6 KO mutation  (+/-) at E9.5 and P2. Visualization and enrichment analysis performed using 
STRING.
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Figure 3.8 Pathway Analysis of Genes with Persistent DMCs Assoc. with FA. On KO 
Background Persistent genes were defined by annotating the intersection of differential sites 
associated with FA mutation at E9.5 and P2. Visualization and enrichment analysis performed 
using STRING.
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3.10 Discussion 
 
 Most exciting was the identification of Folh1 as upregulated by a 
combinatorial mechanism, along with the associations with nervous system 
development and dendrite development noted with FA on the KO background 
and the Cd mutation on the crooked tail background. Intriguingly, they’re both 
found interventions on two different backgrounds that cause negative 
consequences. This may indicate that by causing excess demethylation in 
neuronal development genes, normal function can best not be distrupted. Further 
oxidatizes states of methylation, in particular 5faC, can be used to check active 
demethylation. 
The integrative analysis of methylation and expression provides little 
evidence for the additive model of FA action in embryonic mice, in which either 
the Crooked tail or null mutation generated epigenetic lesions that are then acted 
upon by FA. Rather, FA most probably acts in either an independent or 
combinatorial manner, with more differentially expressed genes supporting the 
independent model in the KO background, and the combinatorial model in the Cd 
background. The lack of additive genes is driven not only by the low numbers of 
sites found linked to the mutation, but also the genes associated with either 
mutation. 
Of the observed genes linked to Wnt signaling, more were observed to be 
associated with RhoA compared to beta-catenin, pointing towards a greater role 
for the non-canonical Wnt PCP pathway. 
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Rn45s warrants further study in the null background, as it was the only 
gene that showed differential methylation and expression correlated with FA on 
the null background, with the differential methylation showing persistence over 
developmental time.  
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Cd Background	 10ppm/2ppm Lrp6
Cd/+/Wt 
# Persistent DMCs 86 43 
Genes with DMCs 
Rara,Adra2a,Sdk1,Sgsh,Dcaf15,Tspan9,Gnb4,
Cacna1e,Hmgcr,Zfp324,Bahcc1,Ggn,Ccne1,Tu
nar,Got1,Nmnat2,Hint2,Wnt2b,Sgms1,Nav1,Klf
6,Smarcal1,Itpr3,Nova1,Rora,Sycn,Scn5a,Moc
s1,Tspan11,Kcnmb2,Pole2,Olfr348,Dbh,Hmga
2,Adm,Fgf7,Irx1,B3glct,Dnase1,Ccdc136,Arhge
f28,Gm765,Erf,Fendrr,Hnf1b,Gabbr2,Gm11468
,Isx,Hivep3,Ctdspl,Gm14207,Tox2,Npy,Arid5a,
Cnnm2,Celsr1,Gm38426,Fgf8,Chrna9,Slc25a1,
Irx4,Tmem41b,Ctsb,Kifc3,Mir701,Gjb3,Rhov,N
qo2,Gnas,Fhit,Crip2,Ndufb9,Nhlrc1,Tbc1d20,La
mp2,Fosb,Idh2,Scaf1,Tgif2,Dpcd,Fbxl20,49334
11E08Rik,Ank1, 
Pigm,P2ry6,Lnpk1,Fry,Zfp804a,Pn
oc,1700095B10Rik,1700052K11Ri
k,Cbfa2t3,Spry1,Espn,Card10,Noc
3l,Kank1,Anxa3,Gm436,Zfp777,An
p32a,1700013G24Rik,Cabp1,Rpl3
4-
ps1,Ctdspl,Dut,Wscd2,Max,Acaa1
a,Kif21a,Usp46,2900026A02Rik,Ct
nnbl1,Fam64a,Igsf11,Ephb1,Agxt,
2610028E06Rik,Tmem104,Evc2,4
930465M20Rik,Rasl10a,Gm14204,
3200001D21Rik,1700092K14Rik,1
700123O21Rik, 
Genes with 
>2 DMCs - - 
 
 
KO Background	 10ppm/2ppm Lrp6
+/-/Wt 
# Persistent DMCs 208 25 
Genes with 
Persistent DMCs 
Smad6,Casz1,Slc6a1,Mir290a,Tnfrsf11a,Foxn3
,Gm5069,Lnpk1,Atg5,Phldb1,Clcn2,Fry,Gpbp1,
Gm53,Hint2,Zswim7,Fasn,Sgms1,Nav1,Nkx6-
3,Gapdh,Slc22a19,Fanci,Oxsm,Hdc,Nova1,Mir
499,Uck2,Ggnbp1,S1pr4,Gm436,Mpnd,Zap70,
Ucp1,Lta4h,Txndc9,Rbks,Ago2,Bhmt2,Adrm1,
Dnase1,Nudt6,Msl3,Zfp444,Gm6602,Fendrr,Rp
l34-
ps1,Kbtbd11,Hnf1b,Pdcd4,Gm11468,Ctdspl,Np
as3,Vps53,Dut,Wscd2,Trex2,Acaa1a,Selk,Fam
69b,Nckap5,Fgf8,Alad,Anln,Tyk2,Ulk4,Stk25,S
ec63,Igsf11,Phb,Rtkn,Hapln1,Ephb1,Ndufb9,N
hlrc1,Noct,Dgkh,Idh2,Bdnf,4930465M20Rik,Fb
xl20,Six3os1,Tor2a,1700092K14Rik,Ank1,Ifnlr1
, 
Tmem209,Hspg2,Col16a1,Rn45s,
Top2b,Sall1,Nme6,4930415O20Ri
k,Irx5,Fktn,Emp1,Mkl2,Adam30,Tcf
7l1,Adgrg1,Slc15a1,Slc39a11,Uqc
c2,Col24a1,Kif26a,Rnf181, 
Genes with 
>2 DMCs Rn45s,Fktn 
Ddost,Hspg2,Tpi1,Cox7c,Rn45s,P
hf8,Ubl4a,Suv39h1,Pole2,Sbk1,Ar
hgef28,Fktn,Rps6ka3,Lmtk3,Gnl3l,
Nucb2,Rai2,1700030C10Rik,Bex6 
 
 
Table 3.4 Persistent Differential Methylation Associated with Lrp6 Mutations and FA. 
Persistent DMCs were defined by he intersection of differential sites associated with either FA 
diet or Lrp6 mutation status at E9.5 and P2. Genes were defined by annotation  of persistent 
DMC to the closest gene. 
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3.11 Materials and Methods 
 
Animals 
All procedures involving animals were carried out in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals 
and were approved by the Institutional Animal Care and Use Committee at Weill 
Cornell Medicine. Mice were housed in climate-controlled Thoren units with a 12 
h light–dark cycle. 
Two strains of mice were used: 
Lrp6 K/O: 
Gene-trap mice in which the Lrp6 locus was inactivated have been 
backcrossed more than 12 generations to the C3H/HeJ background. 
Lrp6Cd:  
Crooked tail (Cd) mice bear a gain-of-function naturally occurring mutation 
in Lrp6, a co-receptor for canonical WNT signaling. 
 
Colony maintenance, embryo harvest and whole blood collection: 
Mating pairs of Lrp6+/−  and  Lrp6Cd+/−  mice were maintained on a defined 
diet containing  2ppm or 10ppm FA (Research Diets Inc., New Brunswick, NJ, 
USA) for two generations prior to tissue or embryo collection. Embryos from 
timed pregnant females were harvested at E9.5 and scored based on the somites 
count. For Lrp6+/- 18-21 somites and for Lrp6Cd/+ 18-20 somites, gDNA and RNA 
was extracted from E9.5 whole embryos simultaneously, (AllPrep DNA/RNA 
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Micro Kit Cat.No 80284 Qiagen). Whole blood from P2 pups was collected by 
cardiac puncture. gDNA from whole blood was extracted , (QIAamp DNA Blood 
Mini Kit Cat. No.  51104 Qiagen) 
 
Genotyping and sexing 
Genotyping was done by PCR. Sex-determination of the animals was 
done by PCR using specific primers for Y chromosome. RNA-seq was used to 
confirm presence of mutation in Cd embryos. 
  
Modeling Interactions  
The following models were applied to both the ERRBS and RNA data, to 
calculate differential methylation and differential expression respectively: 
Diet (10ppm/2ppm)  + Genotype (Het/Wt)+ Sex (M/F)  
+ Diet:Sex  + Genotype:Sex + Diet:Sex 
The first three terms capture primary effects (with the relevant contrast noted in 
parenthesis), while the second three capture potential interactions between them. 
Next the analyses were performed with gender non-corrected, using the following 
model: 
Diet (10ppm/2ppm)  + Genotype (Het/Wt) 
+ Diet:Genotype  (Het:10ppm) 
In the final analysis sites and genes associated with sex, sex-diet, or sex-
genotype were removed. 
  
RNA-seq 
	 72	
Samples were aligned and count matrices generated using the Mason lab’s in 
house processing pipeline, r-make. Outlier samples were detected and removed 
in exploratory analysis using PCA and correlation analysis. Differential 
expression analysis was done using DESeq2, with each background being 
analyzed separately.   
 
Gender Control 
 An effort was made to harvest both male and female samples. This served 
two purposes. First, by examining the output of Male/Female contrasts, we were 
able to validate multiDiff ability to detect expected effects. Second, it allowed us 
to check for interactions of mutation status and maternal diet with gender. For 
final maps of differential methylation, we removed sites that were affected by sex, 
sex-genotype, or sex-diet interactions. 
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CHAPTER 4 
 
Challenges in Genetic and Epigenetic Analyses Related to Human NTDs 
 
 
4.1 Introduction 
 The study of model systems functions first as an area of gaining basic 
biological understanding, and ultimately of providing actionable information for 
human decisions-making, in a medical, research, economic, or ecological 
context. In our examination of the biology of folic acid (FA) in Lrp6 mouse 
mutants, our goal is ultimately to gain such insight into the nature of FA and NTD 
biology in humans. Ongoing national efforts to register NTD affected families and 
recruit them for study has resulted in an expanding pool of genetic and epigenetic 
data for researchers to analyze.  
As discussed above, the study of NTD-FA interactions within a single 
gene, within two of the over 400 mouse models (Harris and Juriloff, 2007, 2010), 
must control for factors such as sex, genetic background, and interactions. The 
complex nature of human NTDs makes it all the more vital that care is taken to 
assess and control for confounders when performing study design, analysis, and 
interpretation.. Below we represent examples that illustrate these challenges with 
respect to sex, population ancestry, and genome interpretation. 
 
4.2 Sex Differences in NTD Incidence and DNA Methylation  
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Human and mouse females are known to be at higher risk for NTDs, 
though it is speculated that it may reflect ‘epigenetic drag’ from the X 
chromosome in which the recruitment of methyl groups for the maintenance of 
imprinting results in hypomethylation in other areas of the genome (Juriloff and 
Harris, 2012). In mice, the female-to-male ratio amongst exencephalic mice 
models where known is approximately 2:1, including in the Cd strain.  
Although we currently we do not have sufficient data to confidently call 
sites associated with gender differences, we did use the result of such calls to 
filter our analysis. As can be seen in the figure below, both mutations show the 
highest number of sites being affected by Gender:Genotype interactions., with 
the largest number of sites being observed with CdHet:Male. Removing the sex 
associated sites from the analyses presented in the previous chapter, although 
necessary, may have removed some of the most dynamic sites.  When unsure 
whether biological sex is a relevant factor in an ongoing study, one approach is to 
investigate what occurs when sex and it’s interactions are included as covariates. 
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Figure 4.1 DMCs Called for Use in Sex Filtering. In order to remove sites 
associated with gender, DMCs were called on both Lrp6 mutant backgrounds, 
including sex (Male/Female), and sex-diet (Male:10ppm) and sex-mutation 
(LHet:Male, CdHet:Male) interactions (q-value<0.01, MMD>25). In both 
backgrounds, these terms were associated with amongst the highest numbers of 
DMCs.
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4.3 Importance of Genetic Ancestry in Methylation and Whole Genome 
Study of Human Data 
Although the primary topic here has been on methylation, the study of 
whole genomes sequence (WGS) data in NTDs is starting to bear preliminary 
results (Lei et al., 2015). A difficult problem (discussed below) has been the 
importance of controlling for ancestry, as variants may display different 
frequencies within different subpopulations, altering the results of analyses 
(Polimanti et al., 2015). Similarly, human methylation data has been discovered 
to mirror ancestry information (Rahmani et al., 2017; Sánchez-Martín et al., 
2015). This has the potential to complicate the data collection and interpretation 
of methylation studies in human NTDs, which are starting to be released (Price et 
al., 2016; Rochtus et al., 2015; Stolk et al., 2013) . Below is a section of currently 
unpublished work, reporting a portion of the results of a WGS analyses in Spina 
Bifida patients, that illustrates the challenges of ancestry within that context.. 
The sample cohort encompassed 283 human subjects including 125 NTD 
cases and 158 healthy unrelated controls, derived from Caucasian, US, and 
Middle Eastern backgrounds. Additional control genomes derive from publically 
available datasets from the 1000 Genomes Project (containing genomes from 
over 2,500 individual ), the NHBLI Exome Project (containing over 6,500 exomes) 
and the Exome Aggregation Consortium (ExAC) (Karczewski et al., 2017), 
(containing over 60,500 exomes). Stringent criteria were used to find 
polymorphisms that are likely to alter gene function or regulation, looking for SB 
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case-enrichment of these changes in coding regions and intergenic regions that 
are associated with enhancers and gene regulatory sites. We identified novel 
genes and gene families that are likely to contribute toward NTD risk.  
GPR161 encodes a ciliary G-protein coupled receptor recently shown to 
be a key regulator of sonic hedgehog signaling, and specifically promotes the 
processing of the GLI3 ligand to Gli3 repressor (Gli3R) (Mukhopadhyay et al., 
2013). Mouse embryos that are homozygous knockouts of Gpr161 die in mid 
gestation and display extensive NTDs. We found an insertion in GPR161 that 
caused a frame shift in the transcript (Q-value = 4 x 10–4 using a permutation 
test, and 3 x 10–3 using SKAT). Confirmed using Sanger sequencing, this 
mutation was identified in seven SB patients from the US sample collection, all of 
which were heterozygous for the detected insertion. 
The discovery of the same mutation in seven cases, and its absence in 
the controls, was highly unusual and prompted us to examine whether these 
individuals might be related despite having been randomly collected.  o 
determine if there was any direct or cryptic relatedness among these individuals 
and the other members of the patient cohort, we used several tools including 
BEAGLE (IBD) coupled with PRIMUS (relatedness).  BEAGLE (Browning and 
Browning, 2011) identifies regions of the region that are identical by descent 
between pairs on individuals using a HMM based-method, while PRIMUS 
(Staples et al., 2014)identifies individuals who are up to third-degree relatives by 
evaluating possible pedigrees. 
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We checked the imputed haplotypes in the GPR161 locus using GATK to 
re-call the genomes both locally around GPR161, and globally at sites in the 
1000 genomes project. The local variants were converted using PLINK (version 
1.90b3w) to PLINK format, and Haploviewer (version 4.1) was used to calculate 
and visualize haplotype blocks.   
Analysis of all SNPs across the genome using PLINK confirmed that these 
seven individuals were not first order relatives, since they all showed p_HAT 
identity by state (IBS) scores in the expected range for random individuals44, 
different haplotypes, and were estimated to not be close relatives. Similarly, the 
local analysis using PLINK identified 314 SNPs in a 60KB window around 
GPR161 in the seven cases, and they all showed distinct haplotypes for each 
individual. We next examined the distribution of IBD lengths in the region 
surrounding GPR161, comparing the mean values for the cases with those of the 
single Puerto Rican (PUR) trio available in the 1K data set, two quartets from 
NTD-affected families with NTD, and PUR plus three additional populations from 
the 1K database (Figure 4.2.1.). Although cryptic relatedness cannot be 
completely ruled out, they are no closer than fourth degree relatives (based on 
BEAGLE plus PRIMUS results). Thus, in the aggregate, a founder effect is 
suggested for this population subset. 
GPR161 intolerance of variants in healthy individuals supports its 
pathogenicity in NTD. Our genomic data are the strongest clinical genetic 
connection yet between NTD and this G-protein coupled receptor, whose 
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localization to the primary cilium is regulated by TULP3-ITF-A, where it functions 
in a positive feedback network to activate the SHH pathway in a cAMP-
dependent manner (Hwang and Mukhopadhyay, 2015). Recently, retinoic acid 
signaling and the canonical Wnt pathways were identified as additional 
downstream targets of GPR161, through transcription factor Cdx1, in the genesis 
of NTDs in the mouse (Li et al., 2015).  
Figure 4.2. Inferences of ancestry and familial relatedness from genomic data.. Distribution 
of the length of IBD regions compared between the 7 cases with GPR161 mutation and 1000 
Genomes populations (1KG). IBD was estimated using BEAGLE. Error bars indicate SE of the 
●
●
●
●
●
●
●
●
PUR_Trio
6C_Family
2C_Family
GPR161_Inds
CEU
CHB
YRI
PUR
PUR Trio
NTD Family
GPR161
1KG
0 500,000 1,000,000 1,500,000 2,000,000 2,500,000
Length_IBD
Po
p
	 80	
mean (not shown for PUR Trio as the number is small). The mean length of IBD of the 7 
cases was well outside of the range of first degree relatives (PUR Trio and NTD Families) and 
was comparable to the means of the 1KG. Population Abbreviations: PUR-Puerto Ricans 
from Puerto Rico, YRI-Yoruba in Ibadan, Nigeria, CHB-Han Chinese in Beijing, China, CEU-
Utah Residents (CEPH) with Northern and Western Ancestry. 2C and 6C are quartets of families 
with NTD, used to compare relatedness here, but were not included in the cohort of 125 cases or 
158 controls. 
 
4.4.4. From Validating Variants to Annotations 
The preceding analysis illustrates in the necessity of thinking about 
ancestry and population stratification from the beginning of performing large 
scale WGS studies. To validate the finding, ancestry, relatedness and inferred 
location had to be computed, sometimes with multiple tools and compared. Part 
of the difficulty was not having direct access to all the patients to attempt to 
verify. However, self report of ancestry may not be reliable, especially in areas 
with highly admixed populations (Burnett et al., 2006; Lins et al., 2011), such as 
in the U.S. or Brazil. Another difficulty, common in bioinformatics, is that the 
relevant software and statistical tools may be novel, and thus the output difficult 
to interpret or subtle analytical mistakes easily made. Expert consultation can 
make a significant difference in ensuring accuracy. 
The final section of this chapter shows the result of comparing different 
variant annotation services. This is an area that has seen continual growth and 
innovation, however there is still a great deal unknown about the genome. 
Following the discussion of ancestry, interpreting a variant cannot be done 
without knowing what population it’s being studied in, hence if a service has 
difficulty assigning the input ancestry, potential skepticism in their remaining 
results may be warranted. 
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4.5 Comparison of Genomic Annotation Services 
 The age of next-generation sequencing has brought with large amounts of 
ever-cheaper data, whose rate of growth continues to accelerate, even as the 
cost of generating it continues to fall. Although the  $1000 genome has been 
announced, the process of annotating and analyzing a genome to find clinically 
relevant variants presents a much more difficult task, and often dominates the 
cost of clinical genomics (Mardis, 2010). This demand for genomic annotation 
has lead to the creation of several commercial services for this purpose. We 
compared the output of three such services: Ingenuity’s Variant Analysis Service, 
GenomeQuest’s GQ-IP, and Omica’s Opal. All three offer the ability to annotate 
and filter variants in order to detect ones that may be deleterious. Using 
comparable filtering processes (see Table 5.1), we generated lists of genes with 
potentially deleterious variants from all three services for twelve (12) sample 
genomes collected from several ongoing studies in our lab. Omicia also offered 
the ability to perform a Variant Annotation, Analysis and Search Tool (VAAST)  
(Yandell et al., 2011) Solo analysis.  The VAAST analyses were used as a 
separate set for comparison. We then submitted these genes to the National 
Institute of Allergy and Infectious Diseases’s  (NIAID’s) Database for Annotation, 
Visualization, and Integrated, Discovery  (DAVID)  (Dennis et al., 2003) functional 
annotation clustering tool, using its default setting (see Methods), and compared 
the resulting lists of annotations.  
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4.5.1 Results 
 The results of comparing the genes identified from each service are shown 
in Table 4.3. The most immediate striking feature is the lack of genes with 
consensus between all three services, even in the less stringent case where the 
Omicia VAAST analysis was not used. Also note the large among of variance in 
the number of genes returned between each service, with GenomeQuest 
consistently returning over approximately 200 variants, compared to ~20 for 
GenomeQuest. Using the additional VAAST analysis offered by Omicia, only two 
individuals (out of 12, 16.6%) had overlap between all three filtered lists, 
consisting of a single gene in both cases. 
The initial comparison of the DAVID annotations, shown in Table 5.4, were 
more promising, with 58% (7/12) of the samples having some consensus 
annotations between all three services in the VAAST comparison, 92% (11/12) in 
the non-VAAST comparison. However, inspection immediately showed that this 
approach has limited clinical utility, due to the lack of specificity of many of these 
consensus annotations, such as the gene ontology (GO) terms “olfaction” and 
“membrane”.  
We chose to further analyze the similarity of the functional annotation 
clusters output by DAVID, which included enrichment scores for each individual 
annotation. We represented the data as a network, using the annotation clusters 
as nodes, and creating edges consisting of annotation terms shared between 
clusters, with edge weights determined by the cumulative enrichment of all such 
	 83	
common terms. We describe this as a network-based comparison of functional 
annotation clusters (NET-COFAC). To assess the robustness of the networks, we 
successively removed edges with higher and higher weights, and measured the 
number of subgraphs generated at each step, and then performed a two-
parameter exponential fit (Figure 4.4). This allowed us to visually assess the 
degree of similarity in the annotation clusters across samples both through the 
underlying curves and by examining the parameter values.  We generated three 
benchmarks sets- a negative control with random lists, a positive control with 
identical lists, and another negative control in which intra-individual gene lists 
were compared by permuting them between samples. Plotting these the NET-
COFAC output parameters for these benchmark, we were able to visually identify 
regions in the parameter space, which corresponded to each individual control 
group. Plotting the actual data for the VAAST and non-VAAST comparisons 
(Figure 4.5), we visually found that their NET-COFAC parameters were fairly 
similar to the intra-sample control, and thus while generally distinguishable from 
comparing random lists, ultimately did not carry much signal. 
As a positive control, we added ten (10) lines to the NA12878 vcf, 
introducing homozygous mutations known to cause common conditions, and 
submitted the file to both the Omicia and Ingenuity services. The list of genes and 
the RefSeq IDs of the introduced variants are given in Table 5(a). The result of 
running this file through the analysis pipeline used for the other files is shown in 
Table 5.5(b). For each service 30% (3/10) of the introduced variants survived the 
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filtering process, with a single gene (HEXA) overlapping. The remaining five 
variants were verified to be in the uploaded data, but not in the final filtered 
variant list. 
 
4.5.2 Genome Annotation Discussion 
 Fundamental questions about current approaches to genomics, both with 
respect to the reference genome (Rosenfeld et al., 2012) and to our ability to 
accurately call variants using a single chemical or software pipeline have already 
been raised .(O’Rawe et al., 2013) Our results indicate that similar uncertainty 
exists when doing downstream analysis and variant annotation.  Just as O’Rawe 
et al indicated the need to use multiple approaches to achieve a greater accuracy 
in calling variants, based on our results, we recommend caution when using any 
genome annotation service on a single individual to identify deleterious variants. 
If one has access to multiple services, then their output should certainly be 
compared, and potentially aggregated in order to attempt to generate higher 
confidence in diagnosing a variant or pathway as a potential target. Of the 
services studied, Omicia’s Opal was the least costly, offering free variant 
annotation, and $100 per sample for further analysis, and thus offers a cost-
effective way to generate a comparison for another pipeline or service.  
 The source of the variation in the identified genes is unknown. As the 
filtering processes were not completely uniform, the slight differences may have 
been the cause of the divergence. Another possibility is that different services 
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used different quality filters when importing the data, thus creating a non-uniform 
pool of initial variants. An additional possibility would be differences in algorithmic 
implementation, or even perhaps an erroneous implementation in one or more of 
the services. Finally, it is possible that the variance would be reduced in duo or 
trios studies, which all three services also offer. 
NET-COFAC was designed as a way to quantify similarity in functional 
annotation clusters. We note that for an actual case, one could for example, use 
the aggregate enrichment scores of all consensus annotations to provide a 
ranking of terms, thus helping to locate terms or pathways that are potentially 
actionable. The variance in the NET-COFAC fit parameters may indicate that 
some genomes are fundamentally more complex than others – “complexity” 
referring here to our ability to identify the functions that are being affected by 
genetic variants. It is not immediately apparent whether such complexity is 
fundamental in nature, or dependent on the reference genome being utilized. 
Further study is needed to probe this question, as well as to how great the 
variance in genome complexity might be within and across populations.  
 
4.5.3 Methods 
 
4.5.3.1 Samples 
Twelve (12) whole genome VCF files were used from ongoing projects 
within the Mason lab. Seven (7) of the genomes were of individuals with medical 
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condition, and five (5) were controls. Their descriptions were: four (4) affected 
children from a neural tube-defect study from two separate families (2C1, 2C2, 
6C1, 6C2), four (4) control genomes of members of the Mason lab (LPA2, LPB2, 
LPC2, LPF1), three (3) subject from the NIH Office of Rare Disease Research’s 
Undiagnosed Diseases Project (UDP)  (UDP441, UDP3427, UDP4823), and the 
1000 Genomes Hi-Seq Whole Genome file for NA12878. The list of sample 
identifiers and their sex and group are given in Table 4.1.  
 
4.5.3.2 Variant Annotation 
The VCF files were submitted to Ingenuity’s Variant Analysis, Omicia’s 
Opal, and GenomeQuest via their online interfaces. The full list of filters for each 
service is described below, and shown in Table 2. The filtering processes where 
kept as similar as possible, and used criteria for filtering suitable for analyzing an 
individual with no prior information about their condition. Liberal thresholds for 
each parameter were generally used. In this way short lists of potentially 
deleterious variants were generated for each service. These lists were compared 
against each other to find consensus genes.  
A summary of the settings used to filter the VCF files and their associated 
genetic variants follows: Variants with a frequency in the population of more than 
10% were filtered out. Their SIFT (Ng and Henikoff, 2003) score, a method based 
on sorting intolerant from tolerant amino acids to predict damaging substitutions 
based on conservation, was required to be less than 0.1. Note that this is higher 
	 87	
than the standard threshold of 0.05 for predicting a damaging mutation, in 
keeping with the liberal approach to the filtering described above. The similar 
PolyPhen [6] score also predicts damaging substitutions, this time based on 
physical considerations. Each service had a filter that screened for protein 
impact, which we applied, again using liberal parameters when possible. At this 
point, we let the procedure diverge to use features unique to each service. For 
Omicia, we required that the variant’s Omicia Score, which is a meta-classifier 
combining SIFT, PolyPhen , MutationTester [8], and phyloP values [9], be above 
75. Omicia, also offered a VAAST (Variant Annotation, Analysis, and Search 
Tool) analysis, which probabilistically identifies damaging genes. Genes that 
were included in the VAAST solo report were used to conduct an additional 
comparison with the other services. For GenomeQuest, we required that the 
variant’s Clinical Significance was not benign, and did not involve drug-response. 
Finally for Ingenuity, we used one of the pre-built filters, which required that the 
observed variant be observed to be or possibly be pathogenic.  
 
4.5.3.3  DAVID Functional Annotation 
The resulting gene lists were submitted to the DAVID  annotation tool for 
functional annotation and clustering, using the default setting. The resulting 
annotation terms were then extracted and compared. The DAVID default settings 
consist of the following annotations:  
Disease: OMIM_DISEASE 
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Functional Categories: COG_ONTOLOGY, SP_OIR_KEYWORDS, 
UP_SEQ_FEATURE 
Gene Ontology: GOTERM_BP_FAT, GOTERM_CC_FAT, 
GOTERM_MF_FAT 
Pathways: BIOCARTA, KEGG_PATHWAY 
Protein Domain: INTERPRO, PIR_SUPERFAMILY, SMART. 
 
4.5.3.4 Network-based Comparison of Functional Annotation Clustering 
(NET-COFAC) 
The DAVID output was used generate the networks for NET-COFAC. 
Analysis was done in Python using the iPython interface and utilizing the 
NetworkX package to programmatically create the graphs and visualize the data. 
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Subject participation was obtained through IRB approved protocols 
reviewed by the state of California and Stanford University, the University of 
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participation in the study. Research was carried out in compliance with the 
Helsinki Declaration. 
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Sample ID Group 
NA12878 Standard Control 
LP_A2 Mason Lab Member 
LP_B2 Mason Lab Member 
LP_C2 Mason Lab Member 
LP_F1 Mason Lab Member 
2C1 Neural Tube Defect, affected 
child, Family 1 
2C2 Neural Tube Defect, affected 
child, Family 1 
6C1 Neural Tube Defect, affected 
child, Family 2 
6C2 Neural Tube Defect, affected 
child, Family 2 
UDP_441 Undiagnosed Diseases Program 
UDP_3427 Undiagnosed Diseases Program 
UDP_4823 Undiagnosed Diseases Program 
Table 4.1 Sample ID and Information. Whole genome files were used from two different 
ongoing studies: one involving neural tube defects in children, the others from the Office of Rare 
Diseases Research’s Undiagnosed Diseases Program. Five (5) controls were also used: the 
standard control sample, NA12878, and four genomes from members of the Mason lab.   
 
Table 4.2. Filters Used with Genome Analysis Services. Filters were selected to be as similar 
as possible. Analysis was done both with the above settings, and excluding the results of the 
Omicia VAAST Solo report. An explanation of the various acronyms and terms follows: SIFT 
(Sorting Intolerant From Tolerant) scores variants based on their effect on conserved amino acid 
substitutions. PolyPhen (Polymorphism Phenotyping) scores variants based on their effect on 
structure and function of proteins. phyloP (Phylogentic P values) assigns a p-value based on 
base-pair resolution conservation and selection-detection.  The Omicia Score is a meta-classifier 
combining SIFT, PolyPhen, MutationTester, and phyloP values. VAAST (Variant Analysis, 
Omicia Filters GenomeQuest Filters Ingenuity Filters 
Frequency: ≤0.1 Minor Allele Frequency: ≤0.10 
Common Variants: 
≤0.10 in 1000 Genomes, 
Complete Genomics,  
OR ESP genomes 
SIFT score : ≤0.1 SIFT Score: ≤0.1 Not tolerated by SIFT 
Polyphen Prediction:  
Probably damaging 
Polyphen: 
Damaging, Probably Damaging Not tolerated by PolyPhen-2 
Protein Impact: All Predicted Impact: is not SILENT 
Genetic Analysis: 
Inferred gain –or loss-of-
function variants (default 
settings) 
Omicia Score: ≥0.75 
Clinical Significance: 
is not benign, drug-response 
Predicted Deleterious: 
Experimentally observed 
Pathogenic 
OR Possibly Pathogenic 
Present in VAAST Solo 
Report   
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Annotation, and Search Tool) probabilistically predicts damaging genes based on prioritizing 
predicted amino substitutions.  
 
A. 
 
Sample ID GenomeQuest Omicia Ingenuity 
GenomeQuest 
& Ingenuity 
GenomeQuest 
& Omicia 
Ingenuity 
& 
Omicia 
GenomeQuest, 
Ingenuity, 
& Omicia 
2C1 266 10 29 2 3 3 0 
2C2 260 14 35 1 3 4 0 
6C1 323 99 45 3 46 8 1 
6C2 295 108 37 2 47 8 0 
LPA2 262 7 35 1 1 3 0 
LPB2 243 11 30 0 2 3 0 
LPC2 266 12 35 2 5 4 0 
LPF1 295 11 30 1 5 2 0 
NA12878 11 4 7 0 0 0 0 
UDP3427 256 6 23 2 2 1 0 
UDP441 247 22 60 4 6 9 0 
UDP4823 193 11 35 1 1 4 1 
 
B. 
  
Sample 
ID GenomeQuest Omicia Ingenuity 
GenomeQuest 
& Ingenuity 
GenomeQuest 
& Omicia 
Ingenuity 
& Omicia 
GenomeQuest, 
Ingenuity, & 
Omicia 
2C1 266 92 29 2 53 6 1 
2C2 260 117 35 1 49 8 0 
6C1 323 99 45 3 46 8 1 
6C2 295 108 37 2 47 8 0 
LPA2 262 97 35 1 12 2 0 
LPB2 243 97 30 0 51 6 0 
LPC2 266 94 35 2 49 9 1 
LPF1 295 95 30 1 52 6 1 
NA12878 11 101 7 0 0 1 0 
UDP3427 256 94 23 2 56 5 1 
UDP441 247 94 60 4 51 9 0 
UDP4823 193 87 35 1 37 9 1 
 
Table 4.3 Consensus of  Gene Lists from Omicia, GenomeQuest and Ingenuity Genome 
Analysis Services. (A) Comparison including Omicia VAAST Solo Report. (B) Comparison 
excluding Omicia VAAST solo report (grey columns are redundant).  Each column gives the 
number of genes in each group, which are not disjoint; the first three columns contain the total 
number of genes returned from each service after filtering. Note the low and often non-existent 
pair wise overlap, and the negligible census amongst all three lists. It is also of note that the non-
VAAST Omicia and GQ lists share significant overlap, indicating the VAAST analysis is an 
important source of divergence. The two genes that were found with triple consensus were 
HYDIN and CDK3, for samples 2C1 and UDP4823 respectively. 
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A. 
 
 
Sample 
ID GenomeQuest Omicia Ingenuity 
GenomeQuest 
& Ingenuity 
GenomeQuest 
& Omicia 
Ingenuity 
& 
Omicia 
GenomeQuest, 
Ingenuity, & 
Omicia 
2C1 626 0 120 76 0 0 0 
2C2 573 17 79 47 17 17 17 
6C1 678 280 188 133 208 87 83 
6C2 586 313 137 99 223 93 80 
LPA2 818 0 104 67 0 0 0 
LPB2 696 0 59 38 0 0 0 
LPC2 608 11 141 99 9 9 9 
LPF1 714 24 89 66 22 22 22 
NA12878 12 9 0 0 5 0 0 
UDP3427 734 4 60 34 0 0 0 
UDP441 537 51 153 98 41 32 30 
UDP4823 487 12 162 105 11 10 10 
 
 
B. 
  
Sample 
ID GenomeQuest Omicia Ingenuity 
GenomeQuest 
& Ingenuity 
GenomeQuest 
& Omicia 
Ingenuity 
& Omicia 
GenomeQuest, 
Ingenuity, & 
Omicia 
2C1 626 205 120 76 175 56 56 
2C2 573 364 79 47 247 43 42 
6C1 678 280 188 133 208 87 83 
6C2 586 313 137 99 223 93 80 
LPA2 818 257 104 67 216 49 45 
LPB2 696 257 59 38 223 40 38 
LPC2 608 309 141 99 263 100 93 
LPF1 714 252 89 66 208 67 65 
NA12878 12 234 0 0 12 0 0 
UDP3427 734 354 60 34 274 34 33 
UDP441 537 202 153 98 174 62 62 
UDP4823 487 286 162 105 211 82 78 
 
 
Table 4.4. Consensus of DAVID Functional Annotation Clustering Terms. (A) Comparison 
including Omicia VAAST Solo Report. (B) Comparison excluding Omicia VAAST solo report (grey 
columns are redundant). The gene lists generated from the filtering process were passed through 
the DAVID functional annotation clustering tool, and the resulting annotations extracted into a 
single list for each service. Each column gives the number of annotations found in each category. 
Note the high degree of variation in consensus. 
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Table 4.5. Consensus DAVID Annotations for Sample LPC2. LPC2 had by far the most 
agreement in its annotations from each service, even though they did not agree in their filtered 
gene lists. Nonetheless, the resulting consensus list does little do point to a clear clinical focus, 
due to the generality of the terms involved, although this could also be attributed to the sample 
being from a healthy control subject. Annotations were done with the DAVID default setting, which 
GO:0000166~nucleotide binding GO:0043169~cation binding 
GO:0000278~mitotic cell cycle GO:0043228~non-membrane-bounded organelle 
GO:0000279~M phase GO:0043232~intracellular non-membrane-bounded organelle 
GO:0001882~nucleoside binding GO:0043233~organelle lumen 
GO:0001883~purine nucleoside binding GO:0043549~regulation of kinase activity 
GO:0003677~DNA binding GO:0044430~cytoskeletal part 
GO:0004672~protein kinase activity GO:0045449~regulation of transcription 
GO:0005524~ATP binding GO:0046872~metal ion binding 
GO:0005654~nucleoplasm GO:0046914~transition metal ion binding 
GO:0005856~cytoskeleton GO:0051174~regulation of phosphorus metabolic process 
GO:0005886~plasma membrane GO:0051252~regulation of RNA metabolic process 
GO:0006350~transcription GO:0051338~regulation of transferase activity 
GO:0006355~regulation of transcription, DNA-
dependent GO:0070013~intracellular organelle lumen 
GO:0006468~protein amino acid phosphorylation IPR000719:Protein kinase, core 
GO:0006793~phosphorus metabolic process IPR007110:Immunoglobulin-like 
GO:0006796~phosphate metabolic process IPR013783:Immunoglobulin-like fold 
GO:0007049~cell cycle IPR017441:Protein kinase, ATP binding site 
GO:0008270~zinc ion binding Immunoglobulin domain 
GO:0009890~negative regulation of biosynthetic process Transcription 
GO:0009991~response to extracellular stimulus active site:Proton acceptor 
GO:0010033~response to organic substance atp-binding 
GO:0010558~negative regulation of macromolecule 
biosynthetic process binding site:ATP 
GO:0010604~positive regulation of macromolecule 
metabolic process disulfide bond 
GO:0010605~negative regulation of macromolecule 
metabolic process dna-binding 
GO:0016021~integral to membrane glycoprotein 
GO:0016310~phosphorylation glycosylation site:N-linked (GlcNAc...) 
GO:0017076~purine nucleotide binding kinase 
GO:0019220~regulation of phosphate metabolic process membrane 
GO:0022402~cell cycle process metal-binding 
GO:0022403~cell cycle phase nucleotide phosphate-binding region:ATP 
GO:0030554~adenyl nucleotide binding nucleotide-binding 
GO:0031224~intrinsic to membrane nucleus 
GO:0031327~negative regulation of cellular biosynthetic 
process signal 
GO:0031667~response to nutrient levels signal peptide 
GO:0031974~membrane-enclosed lumen topological domain:Cytoplasmic 
GO:0031981~nuclear lumen topological domain:Extracellular 
GO:0032553~ribonucleotide binding transcription regulation 
GO:0032555~purine ribonucleotide binding transferase 
GO:0032559~adenyl ribonucleotide binding transmembrane 
GO:0042127~regulation of cell proliferation transmembrane region 
GO:0042325~regulation of phosphorylation Zinc 
GO:0042995~cell projection zinc-finger 
GO:0043167~ion binding 
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includes GO cellular component, biological process, and molecular function annotations, as well 
as KEGG pathways. 
 
 
 (A) 
Condition Gene Chr 
Position 
(hg19) RefSeq ID Ref Alt 
Cystic Fibrosis CFTR 7 117199646 rs113993960 CTT - 
Hemophilia F8 X 154132090 rs4898352 A T 
Sickle Cell HBB 11 5248232 rs334 T A 
Tay Sachs HEXA 15 72637869 rs121907952 C T 
Lactose Intolerance LCT 2 136564701 rs121908936 A T 
Familial Medit. Fever MEFV 16 3293310 rs28940579 A G 
Color Blindness OPN1MW X 153461425 rs104894916 G A 
α1-antitrypsin deficiency SERPINA1 14 94847262 rs17580 T A 
Spinal Muscular 
Dsytrophy SMN1 5 70241990 rs76871093 C T 
Cancer (p53) TP53 17 7578406 rs28934578 C T 
 
(B) 
Ingenuity Omicia Consensus Missed 
HEXA SERPINA1 HEXA CFTR 
LCT HEXA  F8 
SMN1 TP53  HEXA 
   LCT 
   MEFV 
 
Table 4.6. NA12878 Positive Control. The NA12878 vcf file was used to generate a positive 
control file by adding homozygous variants associated with well-studied genetic diseases and 
conditions. (A). Information on the ten (10) introduced variants, including condition, position, and 
associated gene and RefSeq ID. (B) Genes recovered post-filtering from Ingenuity and Omicia 
variant analysis services. In each, 30% (3/10) of the introduced variants survived the filtering 
process, with one gene (HEXA) overlapping. The other five variants were verified to be present in 
the uploaded files, but not in the filtered variant lists. 
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A)  
B)  
Figure 4.3 Network Analysis of Functional Annotation Clustering (NET-COFAC) (A). 
Schematic diagram of a NET-COFAC analysis. Nodes represent functional annotation clusters 
generated by DAVID, edges represent annotation terms they share, edge weights are given by 
the sum of the enrichment of those terms. In NET-COFAC, edges are removed from the network 
at higher and higher thresholds, and the number of resulting subgraphs is counted, until all nodes 
are isolated. Nodes are colored based on the service they belong to;. (B) Network robustness as 
measured using NET-COFAC. The y-axis shows a normalized metric for the degree the network 
has been separated. The x-axis is the edge weight threshold, edges below that threshold have 
been removed. Plots were fitted to a logistic curve.  
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Figure 4.4. Testing NET-COFAC Validity. The parameters generated for the logistic fit from 
NET-COFAC are plotted above for the actual data, and several generated control sets. Identical 
lists form a manner of ‘positive control’ setting an upper bound on how robust the network could 
be. Random lists serve as a negative control. A final intermediate control was generated by 
permuting the gene lists among the samples, for example, comparng the Omicia list from 
UDP441, the GenomeQuest list from NA12878, and the Ingenuity list from LP_C2. 	
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CHAPTER 5 
 
Conclusion 
 
5.1 Overview  
 
 The work done for this thesis had the primary goal of gaining 
understanding of FA’s opposing mechanism of action in Lrp6 Cd and KO 
mutants. The multiDiff package was created to help answer this question, and 
displays superior performance compared to the competing DSS-general method. 
We were able to use it to initially identify thousands of loci associated with the 
Lrp6Cd/+, FA supplementation, and Lrp6Cd/+-FA interactions in P2 Male mice on  
the Cd background. 
We then performed an Integrative analysis of methylation and expression, 
which showed that there was little evidence for an additive model of FA action, in 
which epigenetic lesions generated as a result of Lrp6 dysregulation are acted 
upon. Rather, FA appears to act in either an independent or combinatorial 
manner, with more differentially expressed genes supporting the independent 
model in the Lrp6 KO background, and the combinatorial model in the Cd 
background. We identified Rn45s as a gene of interest in the KO background, 
and Folh1 as a gene of interest in Cd and also noted various differentially 
expressed and methylated genes with known associations with partners of Lrp6  
in  the Cd background, while emphasizing those with known connections to 
mouse NTDs in the KO background.. 
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Ongoing challenges related to WGS and methylation studies in human 
NTDs, were discussed, especially the difficulties of handling sex differences. , 
genetic ancestry, and genomic annotation  
 
5.2 Future Work in Mouse 
 Due to the constraints of the current Lrp6 dataset we are unable to 
robustly estimate and report gender specific effects, though current evidence 
suggests that the number of sites affected by sex and interactions is relatively 
large, and is not confined to chrX. Future data collection may allow us probe this 
question. 
A deeper structural challenge with the current dataset is that the two Lrp6 
mutations are raised on different genetic backgrounds. When analyzed together, 
far more DMCs are detected as being associated with background differences 
than any other effect of interest, which is consonant with the observed variability 
of the effect of mutation according to mouse background (Doetschman, 2009; 
Yoshiki and Moriwaki, 2006). In addition, each additional primary effect adds 
several associated interactions terms. Thus theoretically we would need at 
minimum model with 8 terms if we confined ourselves to binary interactions, to do 
a cross-background analysis together- four primary effects including background, 
and 4 interactions, with therefore 256 possible states. An additional complication 
is that the model would have to be nested, due to the fact that each mutation only 
appears on a single background. It seems possible that that the relatively 
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aggressive calling of the MMD estimate would be highly oversensitive in such a 
use case. 
 A cleaner approach would be to use a CRISPR-Cas9  (Cong et al., 2013; 
Sander and Joung, 2014)  system to edit the Lrp6 locus, so both mutations could 
be studied in the same background. CRISPR-Cas9 is an extremely powerful 
gene editing tool, which has been used to both knock in and knockout genes in 
mice. If the FA-responsiveness of Cd is in fact background dependent, the 
current dataset would have be able to provide even more value, as it would allow 
us to look for signals associated with background-mutation interactions. In 
general CRISPR has the ability to eventually consolidate the field of NTD mouse 
models into a greatly reduced number of background. The precisely manner in 
which such consolidation is unclear, but ideally of course the more human 
physiology a model animal captures the more useful it becomes.  
To shed more light on FA-Lrp6 interactions, the performance of CRISP or 
knock down experiments on the genes of interest fruitful line of pursuit in the 
Crooked tail background, as there are far fewer targets to consider. Doing such 
experiments will help clarify whether the methylation hypothesis of FA action is 
correct.  
 
5.3 Future Work in Human 
 The fundamental complexities of NTD biology, in particular the large 
known environmental effects, continue to make WGS studies difficult until cohorts 
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are assembled of large enough size for robust and replicable identification of 
candidate genes. However, in tension with this is the relatively low prevalence of 
NTD compared to other major neurological disorders , and the efficacy of folic 
acid as a preventative measure. In addition, on many occasions sequencing data 
is anonymized before being given to an analyst. Although this process may not 
be perfect, it still removes more detailed information about the nature of the 
defect. This hinders more focused analyses that might fruitfully be pursued to 
identify genes associated with specific subclasses of NTDs 
However, cheaper and more mobile sequencing technology may 
eventually help overcome some of these difficulties by being able to consistently 
track intra-individual changes in circulating methylation and metabolites. The 
deployment of scale of such omics technologies may prove to be a revolution. 
Just as Facebook has changed attitudes toward privacy, companies such a 23 
and Me may help make it possible for researchers to access more details 
phenotypic inclination and make such analyses possible.  
 
5.4 Closing Thoughts 
 In the age of so-called “Big Data,” biology is simultaneously on the 
frontline and the back foot, as biological NGS data can be accumulated so 
quickly that it overruns both infrastructure and analysts. The data is often big “in 
the wrong direction,” meaning that the number of variables that can be observed 
within a given sample, ranging from expression (~105), methylation (~107), and  
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SNPs (~107), to name the first on an ever growing list, vastly outnumber the 
samples that can be collected, especially when the features vary temporally. Due 
to the complexities of biological systems, it is impossible to “let the data speak for 
itself”. Thus, even in the age of deep learning there will still be considerable need 
to exercise biological insight in the selection of assays, construction of datasets 
and the creation and fine-tuning of analysis. With the combination of strong 
collaborations throughout the field to increase cohorts to robust levels and 
achieve and maintain best analytic practices, the field of NTD research has the 
ability to make great progress in the 21st century. 
 
 
  
  
	 102	
References 
 Agresti,	A.	(2015).	Wiley:	Foundations	of	Linear	and	Generalized	Linear	Models.	Ahuja,	N.,	and	Issa,	J.P.	(2000).	Aging,	methylation	and	cancer.	Histol.	Histopathol.	
15,	835–842.	Akalin,	A.,	Kormaksson,	M.,	Li,	S.,	Garrett-Bakelman,	F.E.,	Figueroa,	M.E.,	Melnick,	A.,	and	Mason,	C.E.	(2012).	methylKit:	a	comprehensive	R	package	for	the	analysis	of	genome-wide	DNA	methylation	profiles.	Genome	Biol.	13,	R87.	Amerongen,	R.	van,	and	Nusse,	R.	(2009).	Towards	an	integrated	view	of	Wnt	signaling	in	development.	Development	136,	3205–3214.	Anders,	S.,	and	Huber,	W.	(2010).	Differential	expression	analysis	for	sequence	count	data.	Genome	Biol.	11,	R106.	Anders,	S.,	Reyes,	A.,	and	Huber,	W.	(2012).	Detecting	differential	usage	of	exons	from	RNA-seq	data.	Genome	Res.	22,	2008–2017.	Aryee,	M.J.,	Jaffe,	A.E.,	Corrada-Bravo,	H.,	Ladd-Acosta,	C.,	Feinberg,	A.P.,	Hansen,	K.D.,	and	Irizarry,	R.A.	(2014).	Minfi:	a	flexible	and	comprehensive	Bioconductor	package	for	the	analysis	of	Infinium	DNA	methylation	microarrays.	Bioinformatics	
30,	1363–1369.	Barfield,	R.T.,	Kilaru,	V.,	Smith,	A.K.,	and	Conneely,	K.N.	(2012).	CpGassoc:	an	R	function	for	analysis	of	DNA	methylation	microarray	data.	Bioinformatics	28,	1280–1281.	Baylin,	S.B.	(2005).	DNA	methylation	and	gene	silencing	in	cancer.	Nat.	Clin.	Pract.	Oncol.	2,	S4–S11.	Beerman,	I.,	and	Rossi,	D.J.	(2015).	Epigenetic	Control	of	Stem	Cell	Potential	During	Homeostasis,	Aging,	and	Disease.	Cell	Stem	Cell	16,	613–625.	Bjornsson,	H.T.,	Sigurdsson,	M.I.,	Fallin,	M.D.,	Irizarry,	R.A.,	Aspelund,	T.,	Cui,	H.,	Yu,	W.,	Rongione,	M.A.,	Ekström,	T.J.,	Harris,	T.B.,	et	al.	(2008).	Intra-individual	change	in	DNA	methylation	over	time	with	familial	clustering.	JAMA	J.	Am.	Med.	Assoc.	299,	2877–2883.	Blencowe,	H.,	Cousens,	S.,	Modell,	B.,	and	Lawn,	J.	(2010).	Folic	acid	to	reduce	neonatal	mortality	from	neural	tube	disorders.	Int.	J.	Epidemiol.	39,	i110–i121.	Bodnar,	L.M.,	Himes,	K.P.,	Venkataramanan,	R.,	Chen,	J.-Y.,	Evans,	R.W.,	Meyer,	J.L.,	and	Simhan,	H.N.	(2010).	Maternal	serum	folate	species	in	early	pregnancy	and	risk	of	preterm	birth123.	Am.	J.	Clin.	Nutr.	92,	864–871.	
	 103	
Booth,	M.J.,	Ost,	T.W.B.,	Beraldi,	D.,	Bell,	N.M.,	Branco,	M.R.,	Reik,	W.,	and	Balasubramanian,	S.	(2013).	Oxidative	bisulfite	sequencing	of	5-methylcytosine	and	5-hydroxymethylcytosine.	Nat.	Protoc.	8,	1841–1851.	Borgel,	J.,	Guibert,	S.,	Li,	Y.,	Chiba,	H.,	Schübeler,	D.,	Sasaki,	H.,	Forné,	T.,	and	Weber,	M.	(2010).	Targets	and	dynamics	of	promoter	DNA	methylation	during	early	mouse	development.	Nat.	Genet.	42,	1093–1100.	Bower,	C.,	and	Stanley,	F.J.	(1989).	Dietary	folate	as	a	risk	factor	for	neural-tube	defects:	evidence	from	a	case-control	study	in	Western	Australia.	Med.	J.	Aust.	150,	613–619.	Browning,	B.L.,	and	Browning,	S.R.	(2011).	A	Fast,	Powerful	Method	for	Detecting	Identity	by	Descent.	Am.	J.	Hum.	Genet.	88,	173–182.	Burnett,	M.S.,	Strain,	K.J.,	Lesnick,	T.G.,	de	Andrade,	M.,	Rocca,	W.A.,	and	Maraganore,	D.M.	(2006).	Reliability	of	self-reported	ancestry	among	siblings:	implications	for	genetic	association	studies.	Am.	J.	Epidemiol.	163,	486–492.	Burren,	K.A.,	Scott,	J.M.,	Copp,	A.J.,	and	Greene,	N.D.E.	(2010).	The	Genetic	Background	of	the	Curly	Tail	Strain	Confers	Susceptibility	to	Folate-Deficiency-Induced	Exencephaly.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	88,	76–83.	Carter,	M.,	Ulrich,	S.,	Oofuji,	Y.,	Williams,	D.A.,	and	Ross,	M.E.	(1999).	Crooked	tail	(Cd)	models	human	folate-responsive	neural	tube	defects.	Hum.	Mol.	Genet.	8,	2199–2204.	Carter,	M.,	Chen,	X.,	Slowinska,	B.,	Minnerath,	S.,	Glickstein,	S.,	Shi,	L.,	Campagne,	F.,	Weinstein,	H.,	and	Ross,	M.E.	(2005).	Crooked	tail	(Cd)	model	of	human	folate-responsive	neural	tube	defects	is	mutated	in	Wnt	coreceptor	lipoprotein	receptor-related	protein	6.	Proc.	Natl.	Acad.	Sci.	U.	S.	A.	102,	12843–12848.	Chang,	H.-Y.,	Suchindran,	C.M.,	and	Pan,	W.-H.	(2001).	Using	the	overdispersed	exponential	family	to	estimate	the	distribution	of	usual	daily	intakes	of	people	aged	between	18	and	28	in	Taiwan.	Stat.	Med.	20,	2337–2350.	Chen,	Y.,	Breeze,	C.E.,	Zhen,	S.,	Beck,	S.,	and	Teschendorff,	A.E.	(2016).	Tissue-independent	and	tissue-specific	patterns	of	DNA	methylation	alteration	in	cancer.	Epigenetics	Chromatin	9,	10.	Colas,	J.-F.,	and	Schoenwolf,	G.C.	(2001).	Towards	a	cellular	and	molecular	understanding	of	neurulation.	Dev.	Dyn.	221,	117–145.	Cong,	L.,	Ran,	F.A.,	Cox,	D.,	Lin,	S.,	Barretto,	R.,	Habib,	N.,	Hsu,	P.D.,	Wu,	X.,	Jiang,	W.,	Marraffini,	L.A.,	et	al.	(2013).	Multiplex	genome	engineering	using	CRISPR/Cas	systems.	Science	339,	819–823.	
	 104	
Copp,	A.J.,	and	Greene,	N.D.E.	(2010).	Genetics	and	development	of	neural	tube	defects.	J.	Pathol.	220,	217–230.	Croen,	L.A.,	Shaw,	G.M.,	Jensvold,	N.G.,	and	Harris,	J.A.	(1991).	Birth	defects	monitoring	in	California:	a	resource	for	epidemiological	research.	Paediatr.	Perinat.	Epidemiol.	5,	423–427.	Dattani,	M.T.,	Martinez-Barbera,	J.P.,	Thomas,	P.Q.,	Brickman,	J.M.,	Gupta,	R.,	Mårtensson,	I.L.,	Toresson,	H.,	Fox,	M.,	Wales,	J.K.,	Hindmarsh,	P.C.,	et	al.	(1998).	Mutations	in	the	homeobox	gene	HESX1/Hesx1	associated	with	septo-optic	dysplasia	in	human	and	mouse.	Nat.	Genet.	19,	125–133.	Deak,	K.L.,	Siegel,	D.G.,	George,	T.M.,	Gregory,	S.,	Ashley-Koch,	A.,	and	Speer,	M.C.	(2008).	Further	evidence	for	a	maternal	genetic	effect	and	a	sex-influenced	effect	contributing	to	risk	for	human	neural	tube	defects.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	82,	662–669.	Deng,	H.-X.,	Chen,	W.,	Hong,	S.-T.,	Boycott,	K.M.,	Gorrie,	G.H.,	Siddique,	N.,	Yang,	Y.,	Fecto,	F.,	Shi,	Y.,	Zhai,	H.,	et	al.	(2011).	Mutations	in	UBQLN2	cause	dominant	X-linked	juvenile	and	adult-onset	ALS	and	ALS/dementia.	Nature	477,	211–215.	Dennis,	G.,	Jr,	Sherman,	B.T.,	Hosack,	D.A.,	Yang,	J.,	Gao,	W.,	Lane,	H.C.,	and	Lempicki,	R.A.	(2003).	DAVID:	Database	for	Annotation,	Visualization,	and	Integrated	Discovery.	Genome	Biol.	4,	P3.	Detrait,	E.R.,	George,	T.M.,	Etchevers,	H.C.,	Gilbert,	J.R.,	Vekemans,	M.,	and	Speer,	M.C.	(2005).	Human	neural	tube	defects:	developmental	biology,	epidemiology,	and	genetics.	Neurotoxicol.	Teratol.	27,	515–524.	Doetschman,	T.	(2009).	Influence	of	Genetic	Background	on	Genetically	Engineered	Mouse	Phenotypes.	Methods	Mol.	Biol.	Clifton	NJ	530,	423–433.	Dolzhenko,	E.,	and	Smith,	A.D.	(2014).	Using	beta-binomial	regression	for	high-precision	differential	methylation	analysis	in	multifactor	whole-genome	bisulfite	sequencing	experiments.	BMC	Bioinformatics	15,	215.	Ebbing,	M.,	Bønaa,	K.H.,	Nygård,	O.,	Arnesen,	E.,	Ueland,	P.M.,	Nordrehaug,	J.E.,	Rasmussen,	K.,	Njølstad,	I.,	Refsum,	H.,	Nilsen,	D.W.,	et	al.	(2009).	Cancer	incidence	and	mortality	after	treatment	with	folic	acid	and	vitamin	B12.	JAMA	J.	Am.	Med.	Assoc.	302,	2119–2126.	Ernest,	S.,	Christensen,	B.,	Gilfix,	B.M.,	Mamer,	O.A.,	Hosack,	A.,	Rodier,	M.,	Colmenares,	C.,	McGrath,	J.,	Bale,	A.,	Balling,	R.,	et	al.	(2002).	Genetic	and	molecular	control	of	folate-homocysteine	metabolism	in	mutant	mice.	Mamm.	Genome	Off.	J.	Int.	Mamm.	Genome	Soc.	13,	259–267.	
	 105	
Esapa,	C.T.,	Benson,	M.A.,	Schröder,	J.E.,	Martin-Rendon,	E.,	Brockington,	M.,	Brown,	S.C.,	Muntoni,	F.,	Kröger,	S.,	and	Blake,	D.J.	(2002).	Functional	requirements	for	fukutin-related	protein	in	the	Golgi	apparatus.	Hum.	Mol.	Genet.	11,	3319–3331.	Fatemi,	M.,	Pao,	M.M.,	Jeong,	S.,	Gal-Yam,	E.N.,	Egger,	G.,	Weisenberger,	D.J.,	and	Jones,	P.A.	(2005).	Footprinting	of	mammalian	promoters:	use	of	a	CpG	DNA	methyltransferase	revealing	nucleosome	positions	at	a	single	molecule	level.	Nucleic	Acids	Res.	33,	e176.	Feng,	H.,	Conneely,	K.N.,	and	Wu,	H.	(2014).	A	Bayesian	hierarchical	model	to	detect	differentially	methylated	loci	from	single	nucleotide	resolution	sequencing	data.	Nucleic	Acids	Res.	42,	e69.	Fu,	Y.,	Dominissini,	D.,	Rechavi,	G.,	and	He,	C.	(2014).	Gene	expression	regulation	mediated	through	reversible	m6A	RNA	methylation.	Nat.	Rev.	Genet.	15,	293–306.	Garrett-Bakelman,	F.E.,	Sheridan,	C.K.,	Kacmarczyk,	T.J.,	Ishii,	J.,	Betel,	D.,	Alonso,	A.,	Mason,	C.E.,	Figueroa,	M.E.,	and	Melnick,	A.M.	(2015).	Enhanced	Reduced	Representation	Bisulfite	Sequencing	for	Assessment	of	DNA	Methylation	at	Base	Pair	Resolution.	J.	Vis.	Exp.	JoVE.	Gelfand,	A.E.,	and	Dalal,	S.R.	(1990).	A	Note	on	Overdispersed	Exponential	Families.	Biometrika	77,	55–64.	Gerwinn,	S.,	Macke,	J.H.,	and	Bethge,	M.	(2010).	Bayesian	inference	for	generalized	linear	models	for	spiking	neurons.	Front.	Comput.	Neurosci.	4.	Gibbs,	W.W.	(2014).	Biomarkers	and	ageing:	The	clock-watcher.	Nat.	News	508,	168.	Gray,	J.D.,	Nakouzi,	G.,	Slowinska-Castaldo,	B.,	Dazard,	J.-E.,	Sunil	Rao,	J.,	Nadeau,	J.H.,	and	Elizabeth	Ross,	M.	(2010).	Functional	interactions	between	the	LRP6	WNT	co-receptor	and	folate	supplementation.	Hum.	Mol.	Genet.	19,	4560–4572.	Gray,	J.D.,	Kholmanskikh,	S.,	Castaldo,	B.S.,	Hansler,	A.,	Chung,	H.,	Klotz,	B.,	Singh,	S.,	Brown,	A.M.C.,	and	Ross,	M.E.	(2013).	LRP6	exerts	non-canonical	effects	on	Wnt	signaling	during	neural	tube	closure.	Hum.	Mol.	Genet.	22,	4267–4281.	Greenberg,	J.A.,	Bell,	S.J.,	Guan,	Y.,	and	Yu,	Y.-H.	(2011).	Folic	Acid	supplementation	and	pregnancy:	more	than	just	neural	tube	defect	prevention.	Rev.	Obstet.	Gynecol.	
4,	52–59.	Gu,	H.,	Smith,	Z.D.,	Bock,	C.,	Boyle,	P.,	Gnirke,	A.,	and	Meissner,	A.	(2011a).	Preparation	of	reduced	representation	bisulfite	sequencing	libraries	for	genome-scale	DNA	methylation	profiling.	Nat.	Protoc.	6,	468–481.	
	 106	
Gu,	T.-P.,	Guo,	F.,	Yang,	H.,	Wu,	H.-P.,	Xu,	G.-F.,	Liu,	W.,	Xie,	Z.-G.,	Shi,	L.,	He,	X.,	Jin,	S.,	et	al.	(2011b).	The	role	of	Tet3	DNA	dioxygenase	in	epigenetic	reprogramming	by	oocytes.	Nature	477,	606–610.	Hansen,	K.D.,	Langmead,	B.,	and	Irizarry,	R.A.	(2012).	BSmooth:	from	whole	genome	bisulfite	sequencing	reads	to	differentially	methylated	regions.	Genome	Biol.	13,	R83.	Harris,	M.J.,	and	Juriloff,	D.M.	(2007).	Mouse	mutants	with	neural	tube	closure	defects	and	their	role	in	understanding	human	neural	tube	defects.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	79,	187–210.	Harris,	M.J.,	and	Juriloff,	D.M.	(2010).	An	update	to	the	list	of	mouse	mutants	with	neural	tube	closure	defects	and	advances	toward	a	complete	genetic	perspective	of	neural	tube	closure.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	88,	653–669.	Hashimshony,	T.,	Zhang,	J.,	Keshet,	I.,	Bustin,	M.,	and	Cedar,	H.	(2003).	The	role	of	DNA	methylation	in	setting	up	chromatin	structure	during	development.	Nat.	Genet.	
34,	187–192.	Hayatsu,	H.	(2008).	Discovery	of	bisulfite-mediated	cytosine	conversion	to	uracil,	the	key	reaction	for	DNA	methylation	analysis--a	personal	account.	Proc.	Jpn.	Acad.	Ser.	B	Phys.	Biol.	Sci.	84,	321–330.	Hellman,	A.,	and	Chess,	A.	(2007).	Gene	Body-Specific	Methylation	on	the	Active	X	Chromosome.	Science	315,	1141–1143.	Horvath,	S.	(2013).	DNA	methylation	age	of	human	tissues	and	cell	types.	Genome	Biol.	14,	R115.	Horvath,	S.,	Bennett,	D.A.,	Lu,	A.T.,	and	Levine,	M.E.	(2015).	Epigenetic	age	of	the	pre-frontal	cortex	is	associated	with	neuritic	plaques,	amyloid	load,	and	Alzheimer’s	disease	related	cognitive	functioning.	Hwang,	S.-H.,	and	Mukhopadhyay,	S.	(2015).	G-protein-coupled	receptors	and	localized	signaling	in	the	primary	cilium	during	ventral	neural	tube	patterning.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	103,	12–19.	Inoue,	A.,	and	Zhang,	Y.	(2011).	Replication-Dependent	Loss	of	5-Hydroxymethylcytosine	in	Mouse	Preimplantation	Embryos.	Science	334,	194.	Inoue,	A.,	Shen,	L.,	Dai,	Q.,	He,	C.,	and	Zhang,	Y.	(2011).	Generation	and	replication-dependent	dilution	of	5fC	and	5caC	during	mouse	preimplantation	development.	Cell	Res.	21,	1670–1676.	Irizarry,	R.A.,	Ladd-Acosta,	C.,	Wen,	B.,	Wu,	Z.,	Montano,	C.,	Onyango,	P.,	Cui,	H.,	Gabo,	K.,	Rongione,	M.,	Webster,	M.,	et	al.	(2009).	The	human	colon	cancer	methylome	
	 107	
shows	similar	hypo-	and	hypermethylation	at	conserved	tissue-specific	CpG	island	shores.	Nat.	Genet.	41,	178–186.	Isono,	K.,	Nemoto,	K.,	Li,	Y.,	Takada,	Y.,	Suzuki,	R.,	Katsuki,	M.,	Nakagawara,	A.,	and	Koseki,	H.	(2006).	Overlapping	Roles	for	Homeodomain-Interacting	Protein	Kinases	Hipk1	and	Hipk2	in	the	Mediation	of	Cell	Growth	in	Response	to	Morphogenetic	and	Genotoxic	Signals.	Mol.	Cell.	Biol.	26,	2758–2771.	Iyer,	L.M.,	Tahiliani,	M.,	Rao,	A.,	and	Aravind,	L.	(2009).	Prediction	of	novel	families	of	enzymes	involved	in	oxidative	and	other	complex	modifications	of	bases	in	nucleic	acids.	Cell	Cycle	Georget.	Tex	8,	1698–1710.	Jain,	M.,	Olsen,	H.E.,	Paten,	B.,	and	Akeson,	M.	(2016).	The	Oxford	Nanopore	MinION:	delivery	of	nanopore	sequencing	to	the	genomics	community.	Genome	Biol.	17,	239.	Ji,	H.,	Ehrlich,	L.I.R.,	Seita,	J.,	Murakami,	P.,	Doi,	A.,	Lindau,	P.,	Lee,	H.,	Aryee,	M.J.,	Irizarry,	R.A.,	Kim,	K.,	et	al.	(2010).	A	comprehensive	methylome	map	of	lineage	commitment	from	hematopoietic	progenitors.	Nature	467,	338–342.	Jiang,	M.,	Stanke,	J.,	and	Lahti,	J.M.	(2011).	The	Connections	Between	Neural	Crest	Development	and	Neuroblastoma.	Curr.	Top.	Dev.	Biol.	94,	77–127.	Jones,	P.L.,	Veenstra,	G.J.,	Wade,	P.A.,	Vermaak,	D.,	Kass,	S.U.,	Landsberger,	N.,	Strouboulis,	J.,	and	Wolffe,	A.P.	(1998).	Methylated	DNA	and	MeCP2	recruit	histone	deacetylase	to	repress	transcription.	Nat.	Genet.	19,	187–191.	Jühling,	F.,	Kretzmer,	H.,	Bernhart,	S.H.,	Otto,	C.,	Stadler,	P.F.,	and	Hoffmann,	S.	(2016).	metilene:	fast	and	sensitive	calling	of	differentially	methylated	regions	from	bisulfite	sequencing	data.	Genome	Res.	26,	256–262.	Juriloff,	D.M.,	and	Harris,	M.J.	(2012).	Hypothesis:	The	female	excess	in	cranial	neural	tube	defects	reflects	an	epigenetic	drag	of	the	inactivating	x	chromosome	on	the	molecular	mechanisms	of	neural	fold	elevation.	Birt.	Defects	Res.	A.	Clin.	Mol.	Teratol.	94,	849–855.	Karczewski,	K.J.,	Weisburd,	B.,	Thomas,	B.,	Solomonson,	M.,	Ruderfer,	D.M.,	Kavanagh,	D.,	Hamamsy,	T.,	Lek,	M.,	Samocha,	K.E.,	Cummings,	B.B.,	et	al.	(2017).	The	ExAC	browser:	displaying	reference	data	information	from	over	60	000	exomes.	Nucleic	Acids	Res.	45,	D840–D845.	Kirke,	P.N.,	Mills,	J.L.,	Molloy,	A.M.,	Brody,	L.C.,	O’Leary,	V.B.,	Daly,	L.,	Murray,	S.,	Conley,	M.,	Mayne,	P.D.,	Smith,	O.,	et	al.	(2004).	Impact	of	the	MTHFR	C677T	polymorphism	on	risk	of	neural	tube	defects:	case-control	study.	BMJ	328,	1535–1536.	
	 108	
Kitzman,	J.O.,	Snyder,	M.W.,	Ventura,	M.,	Lewis,	A.P.,	Qiu,	R.,	Simmons,	L.E.,	Gammill,	H.S.,	Rubens,	C.E.,	Santillan,	D.A.,	Murray,	J.C.,	et	al.	(2012).	Non-invasive	whole	genome	sequencing	of	a	human	fetus.	Sci.	Transl.	Med.	4,	137ra76.	Krueger,	F.,	and	Andrews,	S.R.	(2011).	Bismark:	a	flexible	aligner	and	methylation	caller	for	Bisulfite-Seq	applications.	Bioinforma.	Oxf.	Engl.	27,	1571–1572.	Lehmann-Werman,	R.,	Neiman,	D.,	Zemmour,	H.,	Moss,	J.,	Magenheim,	J.,	Vaknin-Dembinsky,	A.,	Rubertsson,	S.,	Nellgård,	B.,	Blennow,	K.,	Zetterberg,	H.,	et	al.	(2016).	Identification	of	tissue-specific	cell	death	using	methylation	patterns	of	circulating	DNA.	Proc.	Natl.	Acad.	Sci.	113,	E1826–E1834.	Lei,	Y.,	Fathe,	K.,	McCartney,	D.,	Zhu,	H.,	Yang,	W.,	Ross,	M.E.,	Shaw,	G.M.,	and	Finnell,	R.H.	(2015).	Rare	LRP6	variants	identified	in	spina	bifida	patients.	Hum.	Mutat.	36,	342–349.	Li,	B.I.,	Matteson,	P.G.,	Ababon,	M.F.,	Nato,	A.Q.,	Lin,	Y.,	Nanda,	V.,	Matise,	T.C.,	and	Millonig,	J.H.	(2015).	The	orphan	GPCR,	Gpr161,	regulates	the	retinoic	acid	and	canonical	Wnt	pathways	during	neurulation.	Dev.	Biol.	402,	17–31.	Li,	E.,	Beard,	C.,	and	Jaenisch,	R.	(1993).	Role	for	DNA	methylation	in	genomic	imprinting.	Nature	366,	362–365.	Li,	S.,	Garrett-Bakelman,	F.,	Perl,	A.E.,	Luger,	S.M.,	Zhang,	C.,	To,	B.L.,	Lewis,	I.D.,	Brown,	A.L.,	D’Andrea,	R.J.,	Ross,	M.E.,	et	al.	(2014).	Dynamic	evolution	of	clonal	epialleles	revealed	by	methclone.	Genome	Biol.	15,	472.	Lichinchi,	G.,	Gao,	S.,	Saletore,	Y.,	Gonzalez,	G.M.,	Bansal,	V.,	Wang,	Y.,	Mason,	C.E.,	and	Rana,	T.M.	(2016).	Dynamics	of	the	human	and	viral	m6A	RNA	methylomes	during	HIV-1	infection	of	T	cells.	Nat.	Microbiol.	1,	nmicrobiol201611.	Lins,	T.C.,	Vieira,	R.G.,	Abreu,	B.S.,	Gentil,	P.,	Moreno-Lima,	R.,	Oliveira,	R.J.,	and	Pereira,	R.W.	(2011).	Genetic	Heterogeneity	of	Self-Reported	Ancestry	Groups	in	an	Admixed	Brazilian	Population.	J.	Epidemiol.	21,	240–245.	Lister,	R.,	and	Ecker,	J.R.	(2009).	Finding	the	fifth	base:	Genome-wide	sequencing	of	cytosine	methylation.	Genome	Res.	19,	959–966.	Lokk,	K.,	Modhukur,	V.,	Rajashekar,	B.,	Märtens,	K.,	Mägi,	R.,	Kolde,	R.,	Koltšina,	M.,	Nilsson,	T.K.,	Vilo,	J.,	Salumets,	A.,	et	al.	(2014).	DNA	methylome	profiling	of	human	tissues	identifies	global	and	tissue-specific	methylation	patterns.	Genome	Biol.	15,	r54.	Lu,	A.T.,	Hannon,	E.,	Levine,	M.E.,	Hao,	K.,	Crimmins,	E.M.,	Lunnon,	K.,	Kozlenkov,	A.,	Mill,	J.,	Dracheva,	S.,	and	Horvath,	S.	(2016).	Genetic	variants	near	MLST8	and	DHX57	affect	the	epigenetic	age	of	the	cerebellum.	Nat.	Commun.	7.	
	 109	
Mardis,	E.R.	(2010).	The	$1,000	genome,	the	$100,000	analysis?	Genome	Med.	2,	84.	Meissner,	A.,	Gnirke,	A.,	Bell,	G.W.,	Ramsahoye,	B.,	Lander,	E.S.,	and	Jaenisch,	R.	(2005).	Reduced	representation	bisulfite	sequencing	for	comparative	high-resolution	DNA	methylation	analysis.	Nucleic	Acids	Res.	33,	5868–5877.	Mills,	J.L.,	and	Dimopoulos,	A.	(2015).	Folic	acid	fortification	for	Europe?	BMJ	351,	h6198.	Mills,	J.L.,	Rhoads,	G.G.,	Simpson,	J.L.,	Cunningham,	G.C.,	Conley,	M.R.,	Lassman,	M.R.,	Walden,	M.E.,	Depp,	O.R.,	and	Hoffman,	H.J.	(1989).	The	absence	of	a	relation	between	the	periconceptional	use	of	vitamins	and	neural-tube	defects.	National	Institute	of	Child	Health	and	Human	Development	Neural	Tube	Defects	Study	Group.	N.	Engl.	J.	Med.	321,	430–435.	Mohn,	F.,	Weber,	M.,	Rebhan,	M.,	Roloff,	T.C.,	Richter,	J.,	Stadler,	M.B.,	Bibel,	M.,	and	Schübeler,	D.	(2008).	Lineage-Specific	Polycomb	Targets	and	De	Novo	DNA	Methylation	Define	Restriction	and	Potential	of	Neuronal	Progenitors.	Mol.	Cell	30,	755–766.	Molloy,	A.M.,	Pangilinan,	F.,	and	Brody,	L.C.	(2017).	Genetic	Risk	Factors	for	Folate-Responsive	Neural	Tube	Defects.	Annu.	Rev.	Nutr.	Morris,	T.J.,	and	Beck,	S.	(2015).	Analysis	pipelines	and	packages	for	Infinium	HumanMethylation450	BeadChip	(450k)	data.	Methods	72,	3–8.	Mukhopadhyay,	S.,	Wen,	X.,	Ratti,	N.,	Loktev,	A.,	Rangell,	L.,	Scales,	S.J.,	and	Jackson,	P.K.	(2013).	The	ciliary	G-protein-coupled	receptor	Gpr161	negatively	regulates	the	Sonic	hedgehog	pathway	via	cAMP	signaling.	Cell	152,	210–223.	Mulinare	J,	Cordero	JF,	Erickson	J,	and	Berry	RJ	(1988).	PEriconceptional	use	of	multivitamins	and	the	occurrence	of	neural	tube	defects.	JAMA	260,	3141–3145.	Ng,	P.C.,	and	Henikoff,	S.	(2003).	SIFT:	predicting	amino	acid	changes	that	affect	protein	function.	Nucleic	Acids	Res.	31,	3812–3814.	Ockeloen,	C.W.,	Khandelwal,	K.D.,	Dreesen,	K.,	Ludwig,	K.U.,	Sullivan,	R.,	van	Rooij,	I.A.L.M.,	Thonissen,	M.,	Swinnen,	S.,	Phan,	M.,	Conte,	F.,	et	al.	(2016).	Novel	mutations	in	LRP6	highlight	the	role	of	WNT	signaling	in	tooth	agenesis.	Genet.	Med.	Off.	J.	Am.	Coll.	Med.	Genet.	18,	1158–1162.	O’Rahilly,	R.,	and	Müller,	F.	(1994).	Neurulation	in	the	normal	human	embryo.	Ciba	Found.	Symp.	181,	70-82-89.	O’Rawe,	J.,	Jiang,	T.,	Sun,	G.,	Wu,	Y.,	Wang,	W.,	Hu,	J.,	Bodily,	P.,	Tian,	L.,	Hakonarson,	H.,	Johnson,	W.E.,	et	al.	(2013).	Low	concordance	of	multiple	variant-calling	
	 110	
pipelines:	practical	implications	for	exome	and	genome	sequencing.	Genome	Med.	5,	28.	Park,	Y.,	and	Wu,	H.	(2016).	Differential	methylation	analysis	for	BS-seq	data	under	general	experimental	design.	Bioinforma.	Oxf.	Engl.	32,	1446–1453.	Park,	Y.,	Figueroa,	M.E.,	Rozek,	L.S.,	and	Sartor,	M.A.	(2014).	MethylSig:	a	whole	genome	DNA	methylation	analysis	pipeline.	Bioinformatics	30,	2414–2422.	Polimanti,	R.,	Yang,	C.,	Zhao,	H.,	and	Gelernter,	J.	(2015).	Dissecting	ancestry	genomic	background	in	substance	dependence	genome-wide	association	studies.	Pharmacogenomics	16,	1487–1498.	Portela,	A.,	and	Esteller,	M.	(2010).	Epigenetic	modifications	and	human	disease.	Nat.	Biotechnol.	28,	1057–1068.	Price,	E.M.,	Peñaherrera,	M.S.,	Portales-Casamar,	E.,	Pavlidis,	P.,	Van	Allen,	M.I.,	McFadden,	D.E.,	and	Robinson,	W.P.	(2016).	Profiling	placental	and	fetal	DNA	methylation	in	human	neural	tube	defects.	Epigenetics	Chromatin	9,	6.	Puckett,	R.L.,	Moore,	S.A.,	Winder,	T.L.,	Willer,	T.,	Romansky,	S.G.,	Covault,	K.K.,	Campbell,	K.P.,	and	Abdenur,	J.E.	(2009).	Further	evidence	of	Fukutin	mutations	as	a	cause	of	childhood	onset	limb-girdle	muscular	dystrophy	without	mental	retardation.	Neuromuscul.	Disord.	NMD	19,	352–356.	van	der	Put,	N.M.J.,	Trijbels,	F.J.M.,	van	den	Heuvel,	L.P.,	Blom,	H.J.,	Steegers-Theunissen,	R.P.M.,	Eskes,	T.K.A.B.,	Mariman,	E.C.M.,	den	Heyer,	M.,	Frosst,	P.,	and	Rozen,	R.	(1995).	Mutated	methylenetetrahydrofolate	reductase	as	a	risk	factor	for	spina	bifida.	The	Lancet	346,	1070–1071.	Rahmani,	E.,	Shenhav,	L.,	Schweiger,	R.,	Yousefi,	P.,	Huen,	K.,	Eskenazi,	B.,	Eng,	C.,	Huntsman,	S.,	Hu,	D.,	Galanter,	J.,	et	al.	(2017).	Genome-wide	methylation	data	mirror	ancestry	information.	Epigenetics	Chromatin	10,	1.	Ritz,	B.R.,	and	Horvath,	S.	(2015).	Increased	epigenetic	age	and	granulocyte	counts	in	the	blood	of	Parkinson’s	disease	patients.	Robertson,	K.D.,	and	Wolffe,	A.P.	(2000).	DNA	methylation	in	health	and	disease.	Nat.	Rev.	Genet.	1,	11–19.	Rochtus,	A.,	Jansen,	K.,	Van	Geet,	C.,	and	Freson,	K.	(2015).	Nutri-epigenomic	Studies	Related	to	Neural	Tube	Defects:	Does	Folate	Affect	Neural	Tube	Closure	Via	Changes	in	DNA	Methylation?	Mini	Rev.	Med.	Chem.	15,	1095–1102.	Rosenfeld,	J.A.,	Mason,	C.E.,	and	Smith,	T.M.	(2012).	Limitations	of	the	human	reference	genome	for	personalized	genomics.	PloS	One	7,	e40294.	
	 111	
Sánchez-Martín,	F.J.,	Lindquist,	D.M.,	Landero-Figueroa,	J.,	Zhang,	X.,	Chen,	J.,	Cecil,	K.M.,	Medvedovic,	M.,	and	Puga,	A.	(2015).	Sex-	and	Tissue-Specific	Methylome	Changes	in	Brains	of	Mice	Perinatally	Exposed	to	Lead.	Neurotoxicology	46,	92–100.	Sander,	J.D.,	and	Joung,	J.K.	(2014).	CRISPR-Cas	systems	for	editing,	regulating	and	targeting	genomes.	Nat.	Biotechnol.	32,	347–355.	Sebold,	C.D.,	Melvin,	E.C.,	Siegel,	D.,	Mehltretter,	L.,	Enterline,	D.S.,	Nye,	J.S.,	Kessler,	J.,	Bassuk,	A.,	Speer,	M.C.,	George,	T.M.,	et	al.	(2005).	Recurrence	risks	for	neural	tube	defects	in	siblings	of	patients	with	lipomyelomeningocele.	Genet.	Med.	Off.	J.	Am.	Coll.	Med.	Genet.	7,	64–67.	Semenza,	G.L.	(2001).	HIF-1,	O(2),	and	the	3	PHDs:	how	animal	cells	signal	hypoxia	to	the	nucleus.	Cell	107,	1–3.	Shaw,	G.M.,	Schaffer,	D.,	Velie,	E.M.,	Morland,	K.,	and	Harris,	J.A.	(1995).	Periconceptional	vitamin	use,	dietary	folate,	and	the	occurrence	of	neural	tube	defects.	Epidemiol.	Camb.	Mass	6,	219–226.	Smith,	A.D.,	Chung,	W.-Y.,	Hodges,	E.,	Kendall,	J.,	Hannon,	G.,	Hicks,	J.,	Xuan,	Z.,	and	Zhang,	M.Q.	(2009).	Updates	to	the	RMAP	short-read	mapping	software.	Bioinformatics	25,	2841–2842.	Smith,	Z.D.,	Chan,	M.M.,	Mikkelsen,	T.S.,	Gu,	H.,	Gnirke,	A.,	Regev,	A.,	and	Meissner,	A.	(2012).	A	unique	regulatory	phase	of	DNA	methylation	in	the	early	mammalian	embryo.	Nature	484,	339–344.	Smithells,	R.W.	(1984).	Can	vitamins	prevent	neural	tube	defects?	Can.	Med.	Assoc.	J.	
131,	273–276.	Smithells,	R.W.,	Sheppard,	S.,	and	Schorah,	C.J.	(1976).	Vitamin	dificiencies	and	neural	tube	defects.	Arch.	Dis.	Child.	51,	944–950.	Smithells,	R.W.,	Sheppard,	S.,	Schorah,	C.J.,	Seller,	M.J.,	Nevin,	N.C.,	Harris,	R.,	Read,	A.P.,	and	Fielding,	D.W.	(1980).	Possible	prevention	of	neural-tube	defects	by	periconceptional	vitamin	supplementation.	Lancet	Lond.	Engl.	1,	339–340.	Smithells,	R.W.,	Sheppard,	S.,	Schorah,	C.J.,	Seller,	M.J.,	Nevin,	N.C.,	Harris,	R.,	Read,	A.P.,	and	Fielding,	D.W.	(1981).	Apparent	prevention	of	neural	tube	defects	by	periconceptional	vitamin	supplementation.	Arch.	Dis.	Child.	56,	911–918.	Smyth,	G.K.	(2004).	Linear	models	and	empirical	bayes	methods	for	assessing	differential	expression	in	microarray	experiments.	Stat.	Appl.	Genet.	Mol.	Biol.	3,	Article3.	
	 112	
Staples,	J.,	Qiao,	D.,	Cho,	M.H.,	Silverman,	E.K.,	Nickerson,	D.A.,	and	Below,	J.E.	(2014).	PRIMUS:	Rapid	Reconstruction	of	Pedigrees	from	Genome-wide	Estimates	of	Identity	by	Descent.	Am.	J.	Hum.	Genet.	95,	553–564.	Stolk,	L.,	Bouwland-Both,	M.I.,	van	Mill,	N.H.,	Verbiest,	M.M.P.J.,	Eilers,	P.H.C.,	Zhu,	H.,	Suarez,	L.,	Uitterlinden,	A.G.,	and	Steegers-Theunissen,	R.P.M.	(2013).	Epigenetic	Profiles	in	Children	with	a	Neural	Tube	Defect;	A	Case-Control	Study	in	Two	Populations.	PLoS	ONE	8.	van	Straaten,	H.W.,	and	Copp,	A.J.	(2001).	Curly	tail:	a	50-year	history	of	the	mouse	spina	bifida	model.	Anat.	Embryol.	(Berl.)	203,	225–237.	Suh,	J.R.,	Herbig,	A.K.,	and	Stover,	P.J.	(2001).	New	perspectives	on	folate	catabolism.	Annu.	Rev.	Nutr.	21,	255–282.	Sullivan,	G.M.,	and	Feinn,	R.	(2012).	Using	Effect	Size—or	Why	the	P	Value	Is	Not	Enough.	J.	Grad.	Med.	Educ.	4,	279–282.	Sun,	D.,	Xi,	Y.,	Rodriguez,	B.,	Park,	H.J.,	Tong,	P.,	Meong,	M.,	Goodell,	M.A.,	and	Li,	W.	(2014).	MOABS:	model	based	analysis	of	bisulfite	sequencing	data.	Genome	Biol.	15,	R38.	Szklarczyk,	D.,	Morris,	J.H.,	Cook,	H.,	Kuhn,	M.,	Wyder,	S.,	Simonovic,	M.,	Santos,	A.,	Doncheva,	N.T.,	Roth,	A.,	Bork,	P.,	et	al.	(2017).	The	STRING	database	in	2017:	quality-controlled	protein–protein	association	networks,	made	broadly	accessible.	Nucleic	Acids	Res.	45,	D362–D368.	Szwagierczak,	A.,	Bultmann,	S.,	Schmidt,	C.S.,	Spada,	F.,	and	Leonhardt,	H.	(2010).	Sensitive	enzymatic	quantification	of	5-hydroxymethylcytosine	in	genomic	DNA.	Nucleic	Acids	Res.	38,	e181.	Wagner,	J.R.,	Busche,	S.,	Ge,	B.,	Kwan,	T.,	Pastinen,	T.,	and	Blanchette,	M.	(2014).	The	relationship	between	DNA	methylation,	genetic	and	expression	inter-individual	variation	in	untransformed	human	fibroblasts.	Genome	Biol.	15,	R37.	Wallingford,	J.B.	(2005).	Neural	tube	closure	and	neural	tube	defects:	Studies	in	animal	models	reveal	known	knowns	and	known	unknowns.	Am.	J.	Med.	Genet.	C	Semin.	Med.	Genet.	135C,	59–68.	Wallingford,	J.B.,	Niswander,	L.A.,	Shaw,	G.M.,	and	Finnell,	R.H.	(2013).	The	Continuing	Challenge	of	Understanding,	Preventing,	and	Treating	Neural	Tube	Defects.	Science	339,	1222002.	Wang,	D.,	Yan,	L.,	Hu,	Q.,	Sucheston,	L.E.,	Higgins,	M.J.,	Ambrosone,	C.B.,	Johnson,	C.S.,	Smiraglia,	D.J.,	and	Liu,	S.	(2012).	IMA:	an	R	package	for	high-throughput	analysis	of	Illumina’s	450K	Infinium	methylation	data.	Bioinforma.	Oxf.	Engl.	28,	729–730.	
	 113	
Wang,	Y.,	Liu,	Y.,	Ji,	W.,	Qin,	H.,	Wu,	H.,	Xu,	D.,	Turtuohut,	T.,	and	Wang,	Z.	(2015).	Variants	in	MTHFR	gene	and	neural	tube	defects	susceptibility	in	China.	Metab.	Brain	Dis.	30,	1017–1026.	Warden,	C.D.,	Lee,	H.,	Tompkins,	J.D.,	Li,	X.,	Wang,	C.,	Riggs,	A.D.,	Yu,	H.,	Jove,	R.,	and	Yuan,	Y.-C.	(2013).	COHCAP:	an	integrative	genomic	pipeline	for	single-nucleotide	resolution	DNA	methylation	analysis.	Nucleic	Acids	Res.	41,	e117.	Werler	MM,	Shapiro	S,	and	Mitchell	AA	(1993).	PEriconceptional	folic	acid	exposure	and	risk	of	occurrent	neural	tube	defects.	JAMA	269,	1257–1261.	Wheldon,	L.M.,	Abakir,	A.,	Ferjentsik,	Z.,	Dudnakova,	T.,	Strohbuecker,	S.,	Christie,	D.,	Dai,	N.,	Guan,	S.,	Foster,	J.M.,	Corrêa,	I.R.,	et	al.	(2014).	Transient	accumulation	of	5-carboxylcytosine	indicates	involvement	of	active	demethylation	in	lineage	specification	of	neural	stem	cells.	Cell	Rep.	7,	1353–1361.	Wiens,	D.	(2016).	Could	folic	acid	influence	growth	cone	motility	during	the	development	of	neural	connectivity?	Neurogenesis	Austin	Tex	3,	e1230167.	World	Health	Organization.	(2015).	Global	health	estimates	(GHE)–Cause-specific	mortality.	World	Health	Organization	(2015).	Global	health	estimates	(GHE)–Disease	burden.	Wossidlo,	M.,	Nakamura,	T.,	Lepikhov,	K.,	Marques,	C.J.,	Zakhartchenko,	V.,	Boiani,	M.,	Arand,	J.,	Nakano,	T.,	Reik,	W.,	and	Walter,	J.	(2011).	5-Hydroxymethylcytosine	in	the	mammalian	zygote	is	linked	with	epigenetic	reprogramming.	Nat.	Commun.	2,	241.	Xi,	Y.,	and	Li,	W.	(2009).	BSMAP:	whole	genome	bisulfite	sequence	MAPping	program.	BMC	Bioinformatics	10,	232.	Yamaguchi,	Y.,	and	Miura,	M.	(2013).	How	to	form	and	close	the	brain:	insight	into	the	mechanism	of	cranial	neural	tube	closure	in	mammals.	Cell.	Mol.	Life	Sci.	CMLS	
70,	3171–3186.	Yandell,	M.,	Huff,	C.,	Hu,	H.,	Singleton,	M.,	Moore,	B.,	Xing,	J.,	Jorde,	L.B.,	and	Reese,	M.G.	(2011).	A	probabilistic	disease-gene	finder	for	personal	genomes.	Genome	Res.	
21,	1529–1542.	Yoder,	J.A.,	Walsh,	C.P.,	and	Bestor,	T.H.	(1997).	Cytosine	methylation	and	the	ecology	of	intragenomic	parasites.	Trends	Genet.	13,	335–340.	Yoshiki,	A.,	and	Moriwaki,	K.	(2006).	Mouse	phenome	research:	implications	of	genetic	background.	ILAR	J.	47,	94–102.	
	 114	
Zaganjor,	I.,	Sekkarie,	A.,	Tsang,	B.L.,	Williams,	J.,	Razzaghi,	H.,	Mulinare,	J.,	Sniezek,	J.E.,	Cannon,	M.J.,	and	Rosenthal,	J.	(2016).	Describing	the	Prevalence	of	Neural	Tube	Defects	Worldwide:	A	Systematic	Literature	Review.	PLOS	ONE	11,	e0151586.	Zhang,	Y.,	Baheti,	S.,	and	Sun,	Z.	(2016).	Statistical	method	evaluation	for	differentially	methylated	CpGs	in	base	resolution	next-generation	DNA	sequencing	data.	Brief.	Bioinform.	(1996).	Food	Standards:	Amendment	of	Standards	of	Identity	for	Enriched	Grain	Products	to	Require	Addition	of	Folic	Acid;	Correction.	
 
